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Abstract 
 
Background:  
People in the developing countries are increasingly vulnerable to the worldwide epidemic of 
obesity. It is a common modifiable risk factor for all the cardiometabolic diseases including type 2 
diabetes (T2DM). Population-based data on the prevalence of obesity in rural Bangladeshi adults 
based on newly proposed cut off points for Asian population have scarce until recently.  
 
Objective:  
To assess the prevalence of general and central obesity in a rural Bangladeshi population and their 
association with T2DM.  
Methods: 
This study data have retrieved from Chandra Rural Diabetes Study, a population-based cross-
sectional study which was conducted in a rural community called Chandra, 40 km. north of 
Bangladesh’s capital, Dhaka in 2009. The survey was carried out in two phases. The first phase 
consisted of household census of the total population residing in the study locations. Based on the 
census results, a list of all men and women aged 20 years and above was selected in the second 
phase. Required numbers of individuals were selected following a random procedure. Ten villages 
were randomly selected from five areas. The total population of these villages was approximately 
20,000 aged ≥20 years. For this study, 3000 individuals were randomly selected and among them 
2376 (79.2%) participated. Structured questionnaires including socio-demographic parameters, 
anthropometric measurements, blood pressure (BP), and blood glucose values were recorded.  
Age adjusted data for anthropometric indices and diabetes risks were assessed and their 
relationships were examined. Newly proposed cut off points for Asian population had been used 
to define general obesity defined by body mass index (BMI) and central obesity defined by both 
waist circumference (WC) and waist hip ratio (WHR).        
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Results: 
The age standardized prevalence of overweight (BMI 23-<25 kg/m2) and obesity (BMI ≥25 kg/m2) 
were 17.7 (95% confidence interval (CI): 16.1, 19.2%) and 26.2% (95% CI: 24.4, 27.9%), 
respectively. The age standardized prevalence of central obesity based on WC (M ≥90 & F ≥80 cm) 
and WHR (M ≥0.90 & F ≥0.80) were 39.8% (95% CI: 37.9, 41.7%) and 71.6% (95% CI: 69.8, 73.4%) 
respectively. Among the study population 88% had both high BMI (≥25 Kg/m2) and high WC (M ≥90 
& F ≥80 cm) and on the other hand, 92.7% had both high BMI (≥25 Kg/m2) and high WHR (M ≥0.90 
& F ≥0.80). The result shows that prevalence of central obesity was more in female than male. 
Study shows middle age, medium and high socioeconomic status (SES), illiterate, primary and 
secondary education levels, physical inactivity, high consumption of carbohydrate, protein and fat, 
were some significant risk indicators for general and central obesity. The adjusted odd ratio (OR) 
was highest for BMI ≥25 (OR: 2.12, P<0.001) for predicting T2DM compared to BMI ≥23 (OR: 1.26, 
P = 0.228), BMI ≥27.5 (OR: 1.93, P = 0.0.002) and BMI ≥30 (OR: 1.78, P = 0.098). Study also 
indicates that WHR predicted better T2DM risk than WC and BMI for both men and women. ROC 
analysis showed the optimal cut-off points for T2DM detection were at a BMI of 21.2 kg/m2 in men 
and 21.8 kg/m2 in women, WC 82 cm in men and women and WHR 0.93 and 0.87, respectively. 
Conclusions: 
It is apparent that obesity is increasing even in poor rural population. In rural Bangladeshi 
population, the prevalence of both general and central obesity was high among both sexes with 
the use of newly proposed cut off points for Asian population. Women presented with more 
central obesity than men. Gender, diet, physical activity, education level, socioeconomic condition, 
and smoking were associated with the prevalence of obesity. Compared with BMI, measures of 
central obesity, WHR and WC showed a better association with the risk of T2DM for both gender. 
Longitudinal follow-up studies are needed to confirm the risk indicators for obesity found in this 
study.  
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Chapter 1: Introduction 
1. 1 Overview of Bangladesh 
1.1.1 Geography 
Bangladesh, officially known as the People's Republic of Bangladesh is located in the 
northeastern part of the Indian subcontinent on the biggest delta in the world. All three sides of 
Bangladesh are generally surrounded by India with Myanmar on the southeast and the Bay of 
Bengal to its south. Together with the Indian state of West Bengal, it makes up the ethno-
linguistic region of Bengal. In the official Bengali language, the name Bangladesh means 
"Country of Bengal". It has a total area of 144,000 square kilometers. It is among the most 
densely populated countries in the world and has a high poverty rate and vulnerable to natural 
disaster. As the World Bank notes in its July 2005 country brief, the country has made 
exceptional progress in human development in the areas of literacy, gender parity in schooling 
and reduction of population growth (1). However, Bangladesh continues to face a number of 
major challenges, including widespread political and bureaucratic corruption, and economic 
competition relative to the world. 
 
                                               Figure 1.1: Geographic location of Bangladesh 
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1.1.2 Land and Climate 
Bangladesh is a land of rivers that crisscrossed throughout the mostly flat territories of the 
country. A humid, low-lying, alluvial region, Bangladesh is composed mainly of the great 
combined delta of the rivers Padma, Jamuna and Meghna, with a network of numerous rivers 
and canals. Along the southwestern coast is the Sundarbans, a mangrove swamp area with 
numerous low islands. Part of the country there are a few small hills in the north and southeast, 
but most of the country is relatively low and flat. Small portion of the country is more than 12 
meters above sea level and when the normal monsoon starts, one third of cultivated land is 
flooded. However, the estuaries of the Ganges and Bramhaputra rivers have enriched the 
countryside with lush, green and very fertile alluvial soil. Straddling the Tropic of Cancer, 
Bangladeshi climate is tropical with a mild winter from October to March, a hot, humid summer 
from March to June. A warm and humid monsoon season lasts from June to October and 
supplies most of the country's rainfall. Natural calamities, such as floods, tropical cyclones, 
tornadoes, and tidal bores occur every now and then throughout the year, combined with the 
effects of deforestation, soil degradation and erosion. 
 
1.1.3 History 
Remnants of civilization in the greater Bengal region date back four thousand years, when the 
region was settled by Dravidian, Tibeto-Burman, and Austro-Asiatic peoples. The exact origin of 
the word "Bangla" or "Bengal" is not known, although it is believed to be derived from Bang, 
the Dravidian-speaking tribe that settled in the area around the year 1000 BCE (2). Due to its 
location at the intersection of South and South East Asia and its fertile agricultural land, it has 
been invaded and influenced by a large number of racial groups. Numerous influences of 
settlers and invaders have come from India and other neighboring countries to settle, and thus 
contributed to its culture and ethnic variety. Muslim kings ruled the country as a province of 
the Indian subcontinent from the early thirteenth century until the eighteenth century, when 
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the British took over (3).  Dutch and French trading companies as well as the British East India 
Company also visited to trade.  
With India’s independence from the British in 1947, Bengal was partitioned into two parts and 
the largely Muslim east was included into Pakistan and became known as East Pakistan (3). 
After twenty-four years of Pakistani rule, Bangladesh finally became an independent country in 
1971, following a much wounded war known as the Liberation War. 
Since its independence, Bangladesh has tried to rebuild itself despite its long experience of 
violence and damage of war. However, its high population density, recurrent natural disasters 
and political instability have made the task difficult. Thus, Bangladesh still remains one of the 
poorest countries in the world. 
1.1.4 People 
According to the last national survey, conducted in March 2011, the population of Bangladesh 
was about 160 million and  it is the 8th most populous nation in the world, with a population 
density of 900 per square kilometers (4). Although the dramatic decrease in the country’s 
population growth rate from 3 to 1.5 percent in the past ten years; it still remains one of the 
most densely populated countries in the world (4).   
The majority of the population is poor and relatively young; 60% being 25 or younger and 3% 
being 63 or older. Life expectancy at birth is 70 years for both males and females in 2012 (4).  
The literacy rate is low, with only about 56.8 per cent of the population over fifteen years of 
age being able to read and write. Adult male literacy is 61.3 percent and female literacy is 
particularly low at 52.2 percent (4). In Bangladesh, education system is categories in the 
following steps: 
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Primary Level 1-5 year 
Secondary Level 6-10 year 
Higher Secondary Level 11-12 year 
Higher Study  
 Graduation (pass course) 13-14 year 
 Graduation (honours) 13-15 year or more 
 Post-graduation 15/16 year or more 
 
Seventy-two percent of the total populations live in rural areas, even though during recent 
years there has been a large migration from rural to urban areas. The society is characterized by 
a notable degree of ethnic homogeneity, with over 98 per cent of the population sharing a 
common language which is Bangla and English is used in urban centers. Of the total population, 
about 90 per cent are Muslims, 9 per cent Hindus, 1 per cent Buddhists and Christians (4). Table 
2 shows the overall overview of Bangladesh (5). 
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Table 1.1: Country profile- Bangladesh (5) 
Total Population 161 million (July 2012 est.)  
0-14 y 34.3% (male 27 /26 million) 
Under 5 years 19 million 
Low Birth Weight (LBW)  22%  
Under 5 years underweight  (u/r) 33%/43% 
Urban/ Rural 28/72% 
Population growth rate 1.579% (2012 est) 
Birth rate 22.53 births/ 1000  
Infant mortality rate 48.99 deaths/1000 live birth 
Under 5 yrs mortality 52 deaths/1000 live birth 
Child education 80% students enrolled in grade one completed primary 
school 
Only 46% of boys and 53% of girls attend secondary school 
Child  labor 13% (male 18 /female-8) 
Birth registration (urban/ rural) 13/9% 
Total expenditure on health 
care/capita 
48 USD 
Total expenditure on health as % 
of GDP 
3.4% 
 
1.1.5 Economy 
Bangladesh has made significant strides in its economic sector performance since 
independence in 1971. The economy has been growing 5-6% per year since 1999 despite 
political instability, poor infrastructure, insufficient power supplies, and slow implementation of 
economic reforms. The average per capita income is about US $1046 in 2013. Bangladesh is an 
agrarian country, 18.4 per cent of the country’s GDP is accumulated from production related to 
agriculture. This sector provides employment of 45 per cent of Bangladeshi workforce (6). The 
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main agriculture cash crop is rice, although wheat, potatoes, jute, oil seeds, pulses, tea, sugar 
cane and tobacco are the principal cash crops. Vegetables, spices and fruits are also produced. 
Efforts to increase and diversify food production are progressing; however, conventional 
farming methods, frequent natural disasters and an increasing population keep continual 
difficulty on food production.  
The industrial sector, which contributes around 28.6 per cent of the GDP, is dominated by 
garment, textile and jute factories (6). Sugar, shrimp processing, paper and newsprint, 
fertilizers, tanneries, cement, ceramic, shipbuilding and pharmaceutical are other rising 
industries. The country has very limited mineral wealth except for reserves of natural gas, 
widely used for power generation, urea production, domestic and other industrial purposes (6). 
Capital goods, chemicals, iron and steel, textiles, food, and petroleum products are the major 
imports. Western Europe, the United States, India, and China are the main trading partners. 
Currency: Bangladeshi Taka (BDT); BDT 1 = 100 paisa. Average exchange rate in 2012: BDT 80: 
USD 1. 
1.1.6 Life style and physical activity  
Life style of people differs markedly according to rural and urban residences in Bangladesh. 
Women in the rural area have to do different kind of manual works during their daily activities 
even inside the house. Cleaning of house, cooking, washing, taking care of children, taking care 
of cattle, gardening etc. all those requires good physical activities in the rural place. On the 
other hand, city people are exposed to rather easy way of daily life. But economic condition of 
the people and social status do also control the way of life of the people. Like the other Asians, 
Bangladeshi people do not have the tradition of doing extra physical exercise apart from the 
requirement for their occupation in daily life. Most of the women put lots of their efforts in 
house hold activities being a housewife after marriage. However there prevails a marked 
difference in amount of work in household activities between rural and urban set-up and 
socioeconomic status. 
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1.1.7 Food habit  
South Asians consume a smaller amount of protein and greater quantities of total fat, 
monounsaturated fatty acids, eggs, dairy products and carbohydrates (about 60–70% of energy 
intake) compared with Europeans. Bengali food is very similar to that of the rest of the Indian 
subcontinent. Rice and fish are traditional favorites. With an emphasis on fish, vegetables and 
lentils served with rice as a staple diet. Their inherent taste for a spicy, sweet or salty food often 
restrains them to take less cooked vegetables and salad. Frying was commonly used for food 
preparation method and vegetable ghee commonly used for cooking in Bangladesh, contains 
trans-fatty acid levels as high as 50%. Similar to other countries of south Asia sleeping after 
lunch and immediately after late dinner is also a very common tradition in Bangladesh. 
1.1.8 Healthcare Service 
The poor health conditions in Bangladesh are attributed to the lack of healthcare and services 
provision by the government. The Ministry of Health and Family Planning was responsible for 
developing, coordinating, and implementing the national health and mother-and-child health 
care programs. Less than 40 percent of the population has access to the basic health care 
services. The total expenditure on healthcare as a percentage of their GDP was only 3.4% in 
2009 (5). The number of hospital beds per 10,000 populations is 4. Most important thing is that 
the citizens of this country pay most of their health care bills as the out-of-pocket expenditure 
(6). Immunization and family planning programs have been successful but Bangladesh is still the 
world's most densely populated country. Improving health care in Bangladesh will be an 
enormous task. Table 1.2 is showing the Health Workforce in Bangladesh in 2010.  
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1.1.9 Urbanization 
Like many other developing countries, fast urbanization is also big problem in Bangladesh. 
Increasing landlessness, narrow scope of business and unemployment in rural Bangladesh are 
principle reasons for urban migration. Riverbank erosion has also led to urban migration. Dhaka 
city alone is having 2-3 million such impoverished people. In 1961, only about five per cent of 
the total population lived in the urban areas. While into 1991 census reported that about 21 
per cent of the country’s population was residing in urban areas (4). At the present time about 
28 percent people are living in urban areas (4). The rapid increase of the number of urban 
centers of the minimum size category took place between 1974 and 1981. The explanation 
behind this growth may be attributed partly to the increase of a large number of growth 
centers by the government of the recently independent country. About 27 per cent of the total 
urban populations of the country live in Dhaka, the capital and the largest metropolitan city in 
the country. It is the 9th largest city in the world and also 28th among the most densely 
populated cities in the world. In 2008, population in Dhaka was estimated as 12.8 million 
whereas the number increased to about 25 million by the year 2025 (5). 
In addition to the adverse effects, urbanization has also served to underline the gap between 
social classes by reinforcing social inequalities. Although certain aspects of urbanization have 
been regarded as advantageous, the ultimate benefit has been restricted to certain social 
Table 1.2: Health Workforce in Bangladesh in 2010 (6) 
 Total number Density/ 10000 population 
Physicians 43315 3.0 
Nurses & Midwifery personnel 39992 2.7 
Public health workers 6091 0.4 
Community health workers 48692 3.3 
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groups.  For example, whereas urbanization has enhanced access to service and education for 
middle and upper social classes, poor urban dwellers are becoming poorer. Besides, they are 
deprived of essential human necessities, such as food and education, and they still suffer from 
poor health status and bear an enormous disease burden.     
1.1.10 Urbanization and Chronic Diseases in Bangladesh      
Every country that experienced urbanization and industrialization is witnessed with a 
transformation of disease pattern from infectious to non-communicable and chronic diseases.  
During the last three decades Bangladesh experienced a decrease in mortality and fertility rates 
and an increase in life expectancy. At the same time the country has also faced epidemiologic 
transition, expanding industrialization, rising income, improved primary health care services, 
universal immunization and increased knowledge and use of oral dehydration therapy (ORS) 
resulting in increased life expectancy at birth longer than 70 years. But changing in life styles, 
eating habits, sedentary life, increased use of tobacco and degrading environmental conditions 
are likely to develop non-communicable diseases (NCDs). Mainly cardiometabolic disorders, 
diabetes mellitus (T2DM), hypertension (HTN) and coronary heart diseases (CHD) are 
increasing. In terms of the number of lives lost due to ill-health and disability, NCDs account for 
62% of the total disease burden in Bangladesh (5). The under-privileged communities in the 
country are bearing the heaviest toll of this burden. Figure 1.2 shows the burden of chronic 
disease in Bangladesh.  
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                           Figure 1.2: Burden of chronic disease – Bangladesh’ 2010 (WHO) (6) 
In response to the growing burden of NCDs, the Bangladesh government and non-government 
organizations have taken several steps to implement appropriate programs, but there are still 
many areas where they could enhance or strengthen their efforts. The Health, Nutrition, 
Population Sector Programme (HNPSP) has identified three NCDs- cancer, cardiovascular 
diseases and diabetes mellitus- as major public health problems. Therefore surveillance of 
these diseases should be started to assist in formulating country policies and programmes. 
Diabetic Association of Banglaeh has initiated surveillance of diabetes mellitus all over the 
country through it central and affiliated associations (7). 
 
 
 
 
 
 
23 
 
1.2 Burden of Obesity 
 
1.2.1 Burden of Obesity:  Global overview 
 
Overweight and obesity are important clinical and public health burdens worldwide. Over the 
last few decades, there has been an alarming upward trend in the prevalence of obesity both in 
developed and developing countries (8, 9). World Health Organization (WHO) has already 
recognized the magnitude of overweight and obesity as a global public health problem (10, 11). 
In its 2002 World Health Report, the WHO ranked obesity among the top 10 risks to human 
health worldwide (12). The latest WHO projections indicate that at least one in three of the 
world's adult population is overweight and almost one in 10 is obese. Additionally there are 
over 20 million children under age five who are overweight (13). 
In 2008, more than 1.5 billion adults, 20 and older, were overweight. Of these over 200 million 
men and nearly 300 million women were obese (14). In recent years, there has been increasing 
recognition that developing countries that still have a substantial problem of undernutrition are 
now facing an epidemic of both obesity and undernutrition. The highest rate of obesity in Asia 
is in Thailand, where 6.8% of adults are reported to be obese (15). The lowest obesity rates in 
the region are in the less developed parts of Asia: 2∙2% in India and 3∙3% in the Philippines (16, 
17). Growth in population size, population aging, urbanization and changes in lifestyle including 
increases in total calorie intake and reductions in physical activity, all contribute to an epidemic 
of overweight and obesity in developing regions (18). 
Worldwide, Indo-Asian people are among the populations at highest risk for cardiovascular 
disease and its risk factors including T2DM, HTN, dyslipidemia and metabolic syndrome (19). 
Evidence also suggests that associations between body mass index (BMI), percentage of body 
fat and chronic diseases may differ between Indo-Asian and Caucasian populations (20, 21). 
Obesity is also the leading preventable causes of death worldwide. In the United States obesity 
is estimated to cause 0.1 to 0.4 million deaths per year (22), while 1 million (7.7%) of deaths in 
Europe are attributed to excess weight (23, 24). On average, obesity reduces life expectancy by 
24 
 
six to seven years, a BMI of 30–35 kg/m2 reduces life expectancy by two to four years, while 
severe obesity (BMI > 40 kg/m2) reduces life expectancy by ten years (25).  
 
1.2.2 Burden of obesity in Bangladesh 
Population-based data on the prevalence of obesity and its association with cardiometabolic 
risk factors in Bangladeshi adults have been lacking until recently. In 2010, WHO estimated the 
prevalence of over-weight/obesity (BMI ≥25kg/m2) aged over 15 was 8.4% in Bangladesh (26). 
In another study assessed the prevalence of overweight and obesity among women of 
reproductive age in South Asia between 1996-2006 also reported increase trends of prevalence. 
Overweight/obesity prevalence increased from 2.7% to 8.9% in Bangladesh; from 1.6% to 10.1% 
in Nepal; and 10.6% to 14.8% in India (27). According to Bangladesh Demographic Health 
Survey (BDHS) in 2004, prevalence of overweight among urban poor women and rural women 
were 9.1% and 5.5% respectively. In addition, from 1996/97 to 2004, the proportion of women 
with at-risk BMI (≥23) increased from 5.1 to 10.2% in rural areas and 24 to 26% in urban areas 
(28).  
 
1.3 Overview of obesity 
 
1.3.1 Definition and Risk Factors of Obesity 
Obesity is a medical condition in which excess body fat has accumulated to the extent that it 
may have an adverse effect on health, leading to reduced life expectancy and/or increased 
health problems (29).  
Obesity is most commonly caused by a combination of excessive food energy intake and lack of 
physical activity, although a few cases are caused primarily by genes, endocrine disorders, 
medications or psychiatric illness.  The determinants can be classified as modifiable and non-
modifiable (Table 1.3).  
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Table 1.3: Modifiable and non- modifiable risk factors of obesity 
Modifiable risk factors Non-modifiable risk factors  
Dietary factors Age 
Physical inactivity (sedentary life style) Gender 
Socioeconomic status Family history 
Psycho social factors Ethnicity 
Cessation of Smoking Genetic factors 
Endocrine factors  
Oral contraceptive and other drugs  
 
 
1.3.2 Anthropometric indicators and Classification of Obesity 
 
BMI as a measure of general obesity, and WC and WHR as measures of central obesity, have 
been proposed to define obesity (30). The most common measure that has been used is the 
BMI. BMI is calculated as the weight in kilograms divided by the square of the height in meter 
(kg/m2) and its concept dates back to 1869 as Quetelet’s index (31), which was shown as a fairly 
good indicator of general fatness (30,32,33). However, despite its use in epidemiological and 
clinical studies, for a given BMI, the adiposity varies by age, gender and ethnicity (34). Asian 
populations generally have a lower body mass index (BMI) than many other ethnic groups, but 
the association between BMI and glucose intolerance is as strong as in any other population 
(35). 
Since the early 1980s, WHR has been considered more closely correlated with abdominal 
visceral fat than the BMI and a better predictor of CVD or diabetes incidence than the BMI (36 -
39). Since the 1990s, interest in WC has increased because it correlates more closely with 
abdominal visceral fat than either the WHR or BMI (40-42) for identification of cardiometabolic 
risk factors.  
26 
 
The central obesity can be divided into two types in terms of fat distribution and the risk of 
development of the disease. The gynoid type of fat distribution is common in women, where a 
pear shaped indicates heavier deposition of fat around the thighs and buttocks. Individual with 
this type of distribution typically do not develop impaired glucose metabolism. In contrast, the 
android type of fat distribution (apple shape) is more typical of men and features fat deposits 
around the waist and upper abdomen. This pattern is associated with significant risk of HTN, 
cardiovascular diseases and T2DM.  
The use of different anthropometric measures has been proposed by various organizations to 
classify overweight and obesity in adults (Table 1.4) 
 
                  Table 1.4: Classification of overweight and obesity by different international organisation  
 BMI (kg/m
2
) WC (cm) WHR   
 WHO (Global) 
(32) 
WHO (Asian) 
(33) 
WHO 
(43) 
NCEP 
(44) 
IDF* 
(45) 
WHO 
(32) 
IDF* 
(45) 
  
Underweight <18.5 <18.5        
Normal 
weight 
18.5 – 24.9 18.5 – 22.9        
Overweight 25 – 29.9 23 – 24.9        
Obese ≥ 30 ≥ 25 ≥ 94/80 
Men/Women 
>102/88 
Men/ Women 
≥ 94/80 
or ≥ 90/80 
Men/ Women 
≥ 1.0/0.85 
Men/Women 
≥0.94/0.80 
or 
≥0.90/0.80 
Men/Women 
  
WHO: World Health Organisation; NCEP: National Cholesterol Education Program; IDF: International Diabetes Federation; BMI: body mass index; WC: 
waist circumference; WHR: waist hip ratio. *WC of ≥ 94/80 cm in men and women for European, Eastern Mediterranean, Middle East and Sub-
Saharan African and ≥90/80 cm for Chinese,  South Asians and South and Central American men/women, respectively.  
 
The WHO definition classified individuals into different stages of obesity using BMI (32) while 
the National Cholesterol Education Program (NCEP) (33) and IDF classified individuals as obese 
and non-obese, using ethnic-specific WC with purpose to define the metabolic syndrome (45). 
Despite lower BMI, some Asian countries have similar or even higher prevalence of 
cardiometabolic diseases than Western countries. The concept of different cut-offs for BMI, WC 
and WHR for Asian populations have been proposed by the WHO and IDF. 
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1.3.3 Health Hazards of Obesity 
 
Not just a cosmetic problem, obesity is also a positive risk factor in the development of T2DM, 
HTN, gall bladder disease, CHD and certain type of cancers (colorectal, hepatic, renal), 
especially hormone related (endometrial, ovarian, cervical, breast, prostate) ones. There are in 
addition, several associated diseases, which although not usually fatal, cause great deal of 
morbidity in the community. These are varicose veins, abdominal hernia, osteoarthritis of 
knees, hips and lumbar spine, hyperuricemia and gout, sleep apnea, flat feet and psychosocial 
stresses particularly during adolescence. Abdominal obesity is important in the development of 
insulin resistance and metabolic syndrome (hyperinsulinaemia, dyslipidemia, glucose 
intolerance and HTN).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Obesity Health Risks 
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1.4 Health Hazards of Obesity: Diabetes 
 
1.4.1 Overview of Diabetes 
Diabetes mellitus is a chronic metabolic disease characterized by elevated blood glucose levels 
resulting from the body’s inability to produce enough insulin or depleted insulin action, or both. 
The chronic hyperglycemia in diabetes is associated with long-term damage, dysfunction, and 
failure of various organs, especially the eyes, kidneys, nerves, heart, and blood vessels (46).  
There are four main forms of diabetes: 
Type 1 diabetes (formerly known as insulin dependent): Type 1 diabetes is the predominant 
form of the disease in younger age groups, mostly in high income countries, especially in the 
Nordic Countries. However, evidence suggests that T1DM is also increasing both in rich and 
poor countries. 
Type 2 diabetes (formerly named non-insulin dependent): Type 2 diabetes is much more 
common and accounts about 85 to 95% of all diabetes cases worldwide. Once considered a 
disease of the affluence, T2DM is now a global health priority. It is in fact one of the major 
contemporary causes of premature disability and death. In virtually every developed nation, 
diabetes ranks as one of the top two causes of blindness, renal failure, and lower limb 
amputation. The life expectancy of individuals with T2DM may be shortened by as much as 15 
years, with up to 80% dying of cardiovascular disease. The most dramatic increases in T2DM 
have occurred in populations where there have been rapid and major lifestyle changes. These 
include changes in diet, and reductions in physical activity, with consequent increases in the 
prevalence of overweight and obesity. 
Gestational diabetes mellitus (GDM): any degree of glucose intolerance with onset or first 
recognition during pregnancy (47). Gestational diabetes develops in 2-5% of all pregnancies, 
but usually disappears when the pregnancy is over. Women with GDM are likely to develop IGT 
and T2DM in the postnatal period (48) or later life (49-51), and children born from a pregnancy 
complicated by GDM are also at risk of childhood obesity and abnormal glucose metabolism 
(52, 53). 
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Other specific types of diabetes due to other causes, e.g., genetic defects in β-cell function, 
genetic defects in insulin action, diseases of the exocrine pancreas (such as cystic fibrosis), and 
drug- or chemical-induced (such as in the treatment of HIV/AIDS or after organ 
transplantation).  
 
1.4.2 Global burden of diabetes  
DM has already become a worldwide epidemic. The public health burden of DM is growing 
rapidly worldwide. Not only its current prevalence but also the increase of its incidence in the 
near future will create a global health problem. On 20 December 2006, the UN General 
Assembly passed a resolution (61/225) and declared 14 November as the World Diabetes Day 
(54). This landmark Resolution recognizes DM as a chronic, debilitating and costly disease 
associated with major complications that pose severe risks for families, countries and the entire 
world.  
The International Diabetes Federation (IDF) has predicted that the number of individuals with 
DM will increase from 366 million (8.3%) in 2011 to 552 million (9.9%) in 2030, with 80% of the 
disease burden in low and middle-income countries (LMCs). The overall total predicted increase 
in numbers with DM from 2011 to 2030 is 50.7%, at an average annual growth of 2.7%, which is 
1.7 times the annual growth of the total world adult population. Forty-eight percent of the 
anticipated absolute global increase of 186 million people with DM is projected to occur in India 
and China alone (55).  
 
1.4.3 Burden of DM in Bangladesh  
Bangladesh is an agro-based rural country where a vast majority (72%) of the population lives in 
rural areas (56). Like other developing countries Bangladesh has undergone marked economic 
and epidemiologic transition in recent years. Increasing urbanization has been found with a 
sedentary lifestyle, higher calorie food intake and stressful condition, which might have 
contributed to the increasing prevalence of DM (57, 58) and which are now recognized as major 
public health problem in a resource constraint country like Bangladesh. Overall, the health care 
costs among the DM population in Bangladesh are over 118 million USD per year.   
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In 2011, the IDF estimated that 8.4 million people living in Bangladesh had diabetes and in 
which more than 96 percent reported T2DM. By 2030, that number is expected to grow to 16.8 
million. This explosion in diabetes prevalence will place Bangladesh among the top five 
countries (Table 1.5) in terms of the number of people living with diabetes in 2030 (55). It has 
been reported that prevalence of T2DM is more in urban people compare to rural people in 
Bangladesh and onset at a relatively young age and low body mass index (BMI) (59, 60). 
 
Table 1.5 – Top 10 countries for numbers of people aged 20-79 years with diabetes mellitus (DM) in 
2011 and 2030 (55) 
2011  2030 
Country Millions  Country Millions  
China 90.0 China 129.7 
India 61.3 India 101.2 
USA 23.7 USA 29.6 
Russian Federation 12.6 Brazil 19.6 
Brazil 12.4 Bangladesh 16.8 
Japan 10.7 Mexico 16.4 
Mexico 10.3 Russian Federation 14.1 
Bangladesh 8.4 Egypt 12.4 
Egypt 7.3 Indonesia 11.8 
Indonesia 7.3 Pakistan 11.4 
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1.5 Literature Review 
 
1.5.1 Adult prevalence and risk factors for obesity  
Generally, most of the populations experienced an increase in the prevalence of obesity in the 
last decade, most likely due to lifestyle changes associated with urbanization, westernization 
and economic development. Similarly the increase in prevalence of obesity was reported in all 
populations in the WHO MONICA study between the 1980s and 1990s, due to increased energy 
supply (61). In recent years, there has been increasing recognition that developing countries 
that still have a substantial problem of undernutrition are now facing an epidemic of both 
obesity and undernutrition (18). The prevalence of obesity ranged from 0.3 -3.4% in Asian 
Indians, Filipinos, Japanese and Chinese (62) to 4.7 - 9.1% in Thais (63), Hong Kong Chinese (62) 
and Singaporeans (64). The prevalence was between 6.0% and 9.3% in men and 12.0% and 
25.0% in women from Africa (65), Mauritius (66), Brazil (67) and Mongolia (68). The prevalence 
of obesity ranged from 10.0 - 15.5% in the Netherlands, Spain (DORICA) and Sweden (69-71) to 
19.3 - 27.7 % in Finland (72), Spain (73), Australia (74), Canada (75), the UK (76), Italy (77) and 
Mexico (78), with similar rates in men and women. In the USA, the prevalence of obesity was 
over 32.0%, with higher rates in Mexican Americans and Blacks than in Whites (79). The 
increasing trend in prevalence of obesity was observed in most of the populations, with a few 
exceptions; in India, Mongolia and the USA the prevalence did not increase in the last decade. 
The prevalence was doubled in Brazil, China and Thailand. 
Genes, age and female sex (in Central and Eastern Europe, Latin America, Asia and Africa), all 
have been considered as nonmodifiable risk factors for obesity. In 2007, Fat Mass and Obesity 
(FTO) gene variants predisposed individuals to T2DM through their effect on BMI in the 
European population (80). The findings were further confirmed in Chinese (81), Japanese (82), 
Asian Indians (83) and Hispanic and African Americans (84). Obesity increases with age in both 
gender, especially in women (69, 76, 79) with a peak prevalence at 50 - 60 years in developed 
and 40-50 years in developing countries (85). Individuals, particularly women with low 
socioeconomic status (SES), were more obese in highly developed countries mostly (86) but 
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women with high SES were more obese in low- and medium-development regions, such as in 
Africa (86) and India (87). 
 
1.5.2 Obesity as a major risk factor for T2DM  
 
Obesity is one of the major modifiable risk factor for T2DM, HTN and many other chronic 
diseases. Longitudinal studies have shown obesity to be a powerful predictor of T2DM 
development (88, 89). Furthermore, interventions directed at reducing obesity also reduce the 
incidence of T2DM. Several studies indicate that WC or WHR, which reflect visceral (abdominal) 
fat, may be better indicators of the risk of developing T2DM than BMI (39, 90). Thus an 
appropriate definition of obesity, underline causes of obesity and its predictive value in relation 
to T2DM is necessary in intervention strategies in different populations. 
Obese women were at higher risk of developing T2DM during a 14-year follow-up, 5-fold in the 
BMI group of 24.0 - 24.9 kg/m2, 40-fold in 31.0 - 32.9 kg/m2 and 93-fold in the 35.0 kg/m2 
category, compared with the group with BMI of <22.0 kg/m2 in the large Nurse’s Health Study 
(91) as well as in the Male Health Professionals in the USA (92) during a 7-year follow-up. A 20-
year follow-up of the Nurse’s Health Study further confirmed that weight increase as a major 
risk factor for T2DM in all, particularly in Asians (93), which was in agreement with findings 
from others (94). Prospective studies have reported a strong association between daily physical 
activity and reduced risk for developing diabetes, with a relative risk reduction of 15 - 60% (95, 
96). Furthermore, clinical intervention trials have clearly shown that weight reduction with 
healthy diet and physical activity can prevent or at least delay the onset of T2DM in individuals 
with impaired glucose tolerance in Swedish (97), Chinese (98), Finnish (99), American (100), 
Asian Indians (101) and Japanese subjects (102). The relative risk reduction for diabetes ranged 
from 28% in Asian Indians to 67% in Japanese during the intensive intervention period. This 
suggests that weight reduction with a healthy lifestyle is the cornerstone in prevention of 
obesity related conditions such as diabetes. 
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1.5.3 Comparison of General and Central obesity for Predicting T2DM  
In the recent years, there has been increasing speculation over which measure of overweight 
and obesity is best able to discriminate those individuals who are at increased cardiometabolic 
risk.  Epidemiological studies have shown overweight and obesity as an independent risk factor 
of T2DM, HTN, dyslipidaemia and CVD (103, 104). BMI is often used to reflect total body fat 
amounts, whereas the WC and WHR are used as surrogates for intra-abdominal adiposity (40, 
105-107). Central obesity, which suggests excessive deposition of intra-abdominal fat, is also 
found to be an important predictor of cardiometabolic risk. Furthermore, central obesity is 
assumed to play a pivotal role in the development of the ‘metabolic syndrome’ (MS), a term 
given to the clustering of CVD risk factors (108).  
A number of epidemiological studies and meta-analyses of the comparison between different 
anthropometric indices (BMI, WC and WHR) for assessing T2DM and other cardiometabolic risk 
factors have been carried out in different ethnic groups since 1990. Lee et al. (109) conducted a 
meta-analysis involving 10 studies (nine of which were cross-sectional) and over 88 000 
individuals, to determine which of the indices (BMI, WC and WHR) has the best discriminator of 
major cardiovascular risk factors are: HTN, T2DM and dyslipidemias. In both men and women, 
measures of central obesity were superior to BMI as discriminators of cardiovascular risk 
factors, although the differences were small and unlikely to be of clinical relevance. Further, the 
study showed that combining BMI with any measure of central obesity did not improve the 
discriminatory capability of the individual measures. 
A meta-analysis of 35 cohort studies that examined the association between different 
anthropometric measures of obesity and incident diabetes has shown that the pooled relative 
risk for diabetes incidence did not differ significantly between BMI and WC or WHR (110). WC 
(not for Asian men) and WHR were more strongly associated with prevalent diabetes than with 
BMI in Asian and Caucasian women, but these measures did not differ in Caucasian men in the 
Obesity in Asia Collaboration study (OAC) (111). A recently published review article including 17 
prospective and 35 cross-sectional studies that compared the performance of anthropometric 
measures with DM (112) were found inconsistent. For prospective studies, WC showed higher 
association in Mexican Americans and African Americans but higher BMI in Pima Indians. 
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Among cross-sectional studies that have formally tested the differences, most showed a slightly 
higher odds ratio (OR) or larger area under the receiver-operating characteristics (ROC) curve 
for WC than for BMI. All studies included in the review showed that either BMI or WC (or WHR) 
predicted or was associated with T2DM independently, regardless of the controversial findings 
on which of these obesity indicators is better (112). The observations from INTERHEART study 
indicate that WHR shows strongest association with cardiovascular risk compared with BMI or 
WC across 52 populations from every continent (113). Based on prospective and cross-sectional 
studies, BMI, WC and WHR have each been identified as an independent risk factor for DM in 
the Bangladeshi populations studied. Previous reports have also shown that central obesity is a 
stronger predictor of the development of T2DM and other cardiometabolic risk indicators 
including HTN, dyslipidemia and MS in Bangladeshi study subjects (59, 114- 116) which is 
consistent with the findings of others South Asian countries (117).   
 
1.5.4 Optimal Cut-off Point for Anthropometric Indices for Predicting T2DM  
Although there are several instruments to measure total body fat and its distribution, there is 
still no ideal method for the measurement of adiposity (diagnostic definitions) or cut-off points 
that should satisfy the criteria of being accurate, precise, accessible and acceptable worldwide. 
The concept of different cut-offs for different ethnic groups have been proposed by the WHO 
(32, 33), because some ethnic groups have higher cardiovascular and metabolic risks at lower 
BMI. Currently, different definitions for obesity, using WC has been proposed by different 
organizations in various populations. Central obesity, using ethnic-specific WC values, is used 
with the purpose to define the MS. In addition, the recommended cut-off values for WC and 
BMI for detecting diabetes differ among ethnic groups (30-34, 43-45), with lower values for 
Asians and higher for Europeans. However, the comparability of the cut-off values is limited 
within populations of the same ethnicity which may be due to variation in age range of the 
study participants or to the methods applied to determine the optimal cut-off values in 
different studies. All studies aiming to choose BMI and WC cut-off values almost exclusively 
used the ROC curve approach, in which the sum of the sensitivity and specificity was 
maximized, but choosing the WC values using this approach was considered inappropriate 
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(118). Qiao and Nyamdorj et al (119) review (based on 4 prospective and 24 cross-sectional 
studies) has also shown the marked variation in cut-off values between ethnic groups. Tongans 
had the highest BMI and WC optimal cut-off values (not for WHR), followed by studies in the 
USA and the UK. The BMI and WC cut-off values were higher for ethnicities in the USA and the 
UK studies than in their counterparts in their original countries. The optimal cutoff values for 
BMI were 27 - 28 kg/m2 in White men and women (Australia, Germany, France (men only), the 
UK and the USA) but were 30 kg/m2 for men in the NHANES III and 25 kg/m2 for women from 
France. The optimal WC (WHR) cutoff values were 97 - 99 cm (0.95) for white men and 85 cm 
(0.83 - 0.85) for white women living outside the USA and the UK. The values for BMI were 23 - 
24 kg/m2 in Chinese, Japanese, and Thai men and 22 - 23 kg/m2 in Indians. The optimal cut-off 
values for WC were 85 cm (0.90) for Chinese, Japanese, Indian, and Thai men and 75 - 80 cm 
(0.79 - 0.85) for women in these ethnic groups from Asia; the values for other ethnic groups 
were between those for Whites and Asians. White, Chinese, Japanese, Indian and Bangladeshi 
men had higher values than women of these ethnicities, but Thai, Iranian, Iraqi, Tunisian, 
Mexican, African and Tongan men did not. 
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Chapter 2: Rationale, Research Questions and Objectives 
 
2.1 Rationale  
Over the last few decades, there has been an alarming upward trend in the prevalence of 
obesity both in developed and developing countries (8, 9). World Health Organization (WHO) 
has already recognized the magnitude of overweight and obesity as a global public health 
problem (10, 11). The latest WHO projections indicate that at least one in three of the world's 
adult population is overweight and almost one in 10 is obese. Additionally there are over 20 
million children under age five who are overweight (13). Population-based data on the 
prevalence of obesity and its association with cardiometabolic risk factors in Bangladeshi adults 
based on newly proposed cut-off level for Asian population have been lacking until recently.  
Epidemiological studies have shown overweight and obesity as an independent risk factor for 
T2DM (103, 104). Central obesity, which suggests excessive deposition of intra-abdominal fat, is 
also found to be an important predictor of cardiometabolic risk. Commonly used 
anthropometric indicators such as BMI, WC and WHR have been proposed to define obesity in 
epidemiological studies. However, there is controversy regarding which of these 
anthropometric indicators best defines obesity and conveys the highest risk for T2DM and 
other cardiometabolic risks (120-122). Furthermore, the International Association for the Study 
of Obesity and the International Obesity Task Force have suggested lower BMI cutoff values for 
the definitions of overweight (23.0–24.9 kg/m2) and obesity (25.0 kg/m2 or greater) in Asian 
populations (107, 33) because of the observed differences between populations. However, 
there are few reports and only small studies in the south Asian region based on these cut-off 
values. Further, it is not known whether the revised definition of obesity would be valid at a 
population level in terms of being better associated with the consequences of obesity in these 
populations. In the above context, we sought to determine the prevalence of overweight and 
obesity using the Asian-specific definition in a rural Bangladeshi population. We also studied 
factors associated with being overweight or obese in rural Bangladeshi population. It should be 
noted that Bangladesh is an agro based rural country where a vast majority (72%) of the 
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national population lives in rural areas, it is important to collect data on the prevalence of 
obesity and its co-morbidities there (4).  
 
2.2 Hypothesis:  
2.2.1. There is high prevalence of general and central obesity in rural areas in Bangladesh.  
2.2.2 Obesity is a risk indicator of diabetes in rural Bangladeshi population.  
 
2.3 Research questions:  
2.3.1 What is the prevalence of general and central obesity in rural Bangladeshi population?  
2.3.2 Is there any association between obesity and diabetes in rural Bangladeshi population?  
 
2.4 Objective:  
 
2.4.1 Primary objective:  
 To determine the prevalence of general and central obesity in rural Bangladeshi 
population based on newly proposed cut-off level for Asian population. 
 
2.4.2 Secondary objectives:  
 To determine the associated risk indicators for general and central obesity in rural 
Bangladeshi population.  
 To observe the association between obesity and diabetes in rural Bangladeshi 
population.  
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Chapter 3: Research Methodology 
 
3.1 Study design and study site:  
The study was a population-based cross-sectional study which had been conducted in a rural 
community called Chandra, 40 km. north of Bangladesh’s capital, Dhaka in 2009. The survey 
was carried out in two phases. The first phase consisted of household census of the total 
population residing in the study locations. Based on the census results, a list of all men and 
women aged 20 years and above was selected in the second phase. Required numbers of 
individuals were selected following a random procedure.  
                                      Figure 3.1: Study site- Chandra, Gazipur 
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3.2. Study period:  
March 2009 to December 2009. 
 
3.3. Study population:  
Chandra Rural Study was carried out in twenty-five villages of ‘‘Gazipur” district during March 
to December’ 2009. The area is approximately 40 km north of capital Dhaka city. Ten villages 
were randomly selected from those twenty-five villages with a population of approximately 
20,000 aged ≥20 years. For this study, 3,000 individuals were randomly selected and among 
them 2,376 (79.2%) participated. The present analysis is based on 2,293 participants (842 male 
and 1,451female) for whom all the variables were available. The demographic and social 
characteristic profile of the general population of Chandra was described as rural, without 
urban facilities. The main livelihood of the population was agricultural and other agrarian 
activities.  
 
3.4. Inclusion criteria:  
Age: ≥20 years, Sex: both sexes, willing to participate and able to communicate. 
 
3.5. Exclusion Criteria:  
Pregnant women, and self-reported or medical-recorded history of myocardial infarction, renal 
disease, liver disease, tuberculosis, malignant diseases and any severe infection at the time of 
screening. 
 
3.6. Sample size of primary study: In 2009 study, 3000 randomly selected individuals were 
invited to participate in the study and among them 2376 (79.2%) participated.  
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3.7. Study variables:  
3.7.1. Socio-demographic variables: age, sex, economic status, education status, smoking 
habit, physical activity, dietary habit  
3.7.2. Anthropometric variables: height, weight, body mass index (BMI), waist circumferences 
(WC), waist height ratio (WHR)  
3.7.3. Clinical and Biochemical variables: Systolic blood pressure (SBP), diastolic blood pressure 
(DBP), hypertension (HTN), fasting plasma glucose (FPG), 2 hour plasma glucose, total 
cholesterol (T-Chol), impaired fasting glucose (IFG), impaired glucose tolerance (IGT), diabetes 
(T2DM), triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein 
cholesterol (LDL-C)  
 
3.8. Data collection:  
Data were taken from the 2009 Chandra Rural Study - a joint research initiative of Diabetes 
Association of Bangladesh and University of Oslo funded by Norwegian Research Council. In 
2009, the study was consisted of two phases of data collection. Household census followed by 
sample survey and collection of other forms of data.  
 
3.8.1. Phase 1: Household census:  
At the beginning of the study, community leaders residing in the area were invited to a 
discussion meeting with the project team leader. They were oriented about the purpose of the 
study and requested to give their comments about the study. Their co-operation was 
appreciated in a participatory manner. Each of the community leaders was given specific task. 
For example, organizing or collecting household list, coordinating with the project field team, 
and providing feedback to the project team based on their background and interest. Sixteen 
volunteers were recruited in four teams from the local community and were trained by the 
project team leader. In addition, four physicians were employed to supervise the project work. 
Three days of training, both theoretical and practical, for the project workers were conducted 
prior to the commencement of the study. The study team moved from village to village 
collecting the required information.  
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The first phase of census survey was carried out during the months of March to December 
2009. Approximately 20,000 inhabitants aged 20 years and above were listed from the 10 
selected villages. All individuals were given an identification number including a household 
number. All men and women aged 20 years and above were considered eligible except 
pregnant women and subjects, who were unwilling to participate. The eligible participants were 
informed about the objectives of the study. They were also informed about the site and 
procedural details of the investigation. After collecting informed consent, each interested 
individual was requested to attend a specific nearby project site after overnight fasting for at 
least 12 hours. 
3.8.2. Phase 2: Sample survey and collection of other data:  
 
3.8.2.1. Sample survey:  
Upon arrival in the field sites, different sets of investigations and physical examinations were 
done for each of the subjects taking part in the study. At first, an initial blood sample was taken 
to estimate the fasting plasma glucose (FPG). Then all the subjects were given 75 gram oral 
glucose to drink and requested to wait for 2-hours for second blood sample collection. During 
this 2-hour waiting time, they were interviewed for collection of socio-demographic 
information. After completion of the interview, the anthropometric measurements including 
height, weight, hip and waist girth were taken. In addition, blood pressure was recorded at this 
time followed by physical examination to find out whether there was any anemia, jaundice, and 
enlarged liver or enlarged spleen. After 2 hours, a second blood sample for OGTT was done by 
glucose analyzer. Details of all the investigations and physical examinations are written below.  
 
3.8.2.2. Anthropometrical measurements  
Anthropometric measurements including height, weight, and waist and hip circumferences 
were taken with the subjects wearing light clothes and without shoes. Weight was recorded to 
the nearest 0.1 kg using electronic digital LCD weighing machines (Best Deluxe Model; 
Bathroom, Dhaka, Bangladesh) placed on a flat surface. The scales were placed on a flat surface 
and calibrated using a standard (20 kg) each day. Height was taken while the subjects stood in 
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erect posture, touching the occiput, back, hip, and heels on a straight measuring wall, while the 
subjects looked straight ahead. Body mass index was calculated as the weight (Kg) divided by 
square of the height (m2). Waist circumference was measured by placing a tape horizontally 
midway between the lower border of the ribs and upper border of iliac crest on the mid-axillary 
line. Hip circumference was measured to the nearest centimeter at the greatest protrusion of 
the buttocks, just below the iliac crest. WHR was then calculated from waist (cm) and hip 
circumference (cm).  
 
3.8.2.3. Measurement of blood pressure:  
Special precaution was taken to reduce the variation of BP value with resting blood pressure; 
subjects were asked to relax and take rest for 5 minutes in sitting position before measuring the 
BP. Then the pressure was measured on the right arm using normal cuffs for adult fitted with a 
standard sphygmomanometer placing the stethoscope bell lightly over the brachial artery. 
Blood pressure was recorded to the nearest 2 mmHg from the top of the mercury meniscus. 
Systolic pressure was recorded at the first appearance of sounds, and diastolic pressure was 
measured at phase V, that is, the disappearance of sounds. 
 
3.8.2.4. Blood glucose estimation:  
On arrival at the field center, an 8 ml fasting venous blood sample was taken from each 
participant for measuring fasting plasma glucose (FPG) and fasting lipids profiles. All 
participants other than those with known diabetes had a 75 gm oral glucose tolerance test. 
Each participant was given a 75 gm oral glucose solution (75 gm oral glucose in 250 ml of water) 
to drink. Another 3 ml of venous blood was collected after 2 hours to determine the 2 hour 
plasma glucose level (2hPG). Venous plasma blood samples were collected in a tube containing 
sodium fluoride and potassium oxalate (1:3) and were centrifuged immediately after collection. 
Separated plasma samples were sent in ice gel packed cooling boxes to the laboratory of 
Bangladesh Institute of Research and Rehabilitation for Diabetes, Endocrine and Metabolic 
Disorders (BIRDEM), and stored at -700C until laboratory assays were completed. Plasma 
glucose was measured using a glucose oxidase method and the Dimalesion RxL Max (Siemens 
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AG, Erlangen, Germany) on the same day. Quality control on the blood glucose measurements 
was checked by measuring the 2 h plasma glucose values using the glucose oxidase method in 
every tenth sample. The intra-assay coefficient of variation was 1.24% at a mean of 5.86 
mmol/l, and the inter-assay coefficient of variation was 2.10% at a mean of 5.23 mmol/l.  
 
 
3.8.2.5. Fasting blood lipids estimation:  
Fasting serum lipid profile was estimated by standard enzymatic procedures (DimalesionRxL 
Max). HDL-C was estimated by the direct assay method and LDL-C was estimated by 
Friedewald’s formula.  
 
3.8.2.6. Methods and specification of the machines for the various laboratory tests  
Test  
 
 
Sample  
 
Method  Specification of Machine 
Measurement 
Type 
 
 
Name of the analyser 
OGTT 
 FPG 
 2h AG 
Venous 
Plasma 
Glucose oxidase End point  Dimension RxL Max 
(Siemens AG, Erlangen, 
Germany) 
T-Chol Serum CHOD-PAP End point  Do 
TG Serum GPO-PAP End point  Do 
HDL Serum Differential 
Precipitation 
End point  Do 
LDL Serum Friedewald’s Formula End point  Do 
 
3.8.2.7. Food behavior questionnaire:  
Food consumption was assessed with the 24-hour recall method. The participants were shown 
various standardized utensils such as serving plates, cups, spoons and models of different foods 
to get the nearest possible approximation of serving sizes of the cooked food consumed. The 
serving weight of different food items was calculated from this information. Equivalent raw 
food weight was obtained by using a conversion table for Bangladeshi foods developed at the 
Institute of Nutrition and Food Science (INFS) (123), University of Dhaka. A program package, 
based on Bangladeshi and Indian food composition table (124,125) was used to calculate the 
nutrients from raw weight of edible portion of food. 
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3.8.2.8. Definition of terms:  
Cut off points for general obesity for both sexes were a BMI of ≥25 kg/m2 (33), cut off points for 
central obesity including WC for men and women were ≥90 and ≥80 cm (45), WHR for men 
≥0.90 and women for ≥0.80 (33, 45, 107) respectively. DM was defined as FPG ≥7.0 mmol/l 
and/or 2hPG ≥11.1 mmol/l (126). In addition, known diabetes was defined by the use insulin or 
oral antidiabetic medication(s) and self-reported DM. Individuals were considered to have HTN 
if their average systolic blood pressure was ≥140 mmHg or diastolic blood pressure was ≥90 
mmHg, or if they were receiving treatment for HTN (127). Dyslipidemia was defined as serum 
triglycerides ≥1.70 mmol/L and HDL-C <1.04 mmol/L for men and <1.29 mmol/L for women. 
Smoking habit was classified as either current or non/ex-smoker and based the monthly 
expenditure socio-economic condition was classified as low (<6000 Bangladeshi Taka [BDT, 1 
USD = 84 BDT]), medium (6000-11000 BDT) and high (>11000 BDT). Education level graded as 
illiterate: unable to write and read; under graduate: having primary and higher secondary 
education; graduate. Physical activity was graded on the ordinal scale of 1-3, corresponding to 
light, moderate and heavy, according to the activity level based on their occupation. For the 
purpose of data analysis, these results were transformed into a binary variable - inactive (grade 
1) and active (grade 2 and 3). 
3.9. Statistical analysis:  
The present analysis was based on 2,293 participants for whom all data were available. Both 
STATA 11 for Windows (STATA Co., College Station, TX, USA) and PASW statistics version 18 for 
Windows (SPSS Inc., Chicago, IL, USA) were used as needed. Means and Percentages with 95% 
confidence intervals adjusted for age were given for normally distributed continuous variables 
and categorical variables as needed. Highly skewed variable (TG) was logarithm transformed 
before analysis and the result was transformed back to the original. Age specific and age 
standardized prevalence by direct standardization method were estimated on the basis of 2001 
census data before performing statistical tests (128). Differences between the groups of means 
and proportions adjusted for age were tested by analysis of covariance (ANCOVA) and logistic 
regression. Logistic regression analysis was also tested for observing association between 
45 
 
obesity indices and diabetes. Multiple logistic regression analyses were also used to study the 
association of risk variables with general and central obesity. Sensitivity and specificity were 
examined by the receiver operating characteristic (ROC) analysis (129,130), and the areas under 
curve (AUC) cut-off values were calculated for each anthropometrical parameter. Statistical 
inference is based on 95% confidence intervals (CIs) and the significance level was set at 0.05.  
 
3.10 Ethical Consideration 
The study was carried out in accordance with the Declaration of Helsinki as revised in 2000 
(131). The local leaders of the project areas were invited to a discussion meeting with the 
project team. They were oriented about the purpose of the study and requested to give their 
comments about the study. Their comments and suggestions were incorporated into the study 
design. In addition, to enhance the acceptability of the study, volunteer were recruited from 
the local people. 
Informed verbal consent was obtained from all study subjects. Approximately 72% of the adult 
population is illiterate in Bangladesh, therefore written consent was not sought in order to 
avoid selection bias. Prior to enrolment in the study, interviewers read out to each potential 
respondent a paragraph that described the purpose of the study and sought verbal consent to 
include them into the study. All respondents were informed that they were free to leave or to 
refuse to take part in the research at any time. The respondents who did not show interest in 
being included in the research were not included. 
Data collected for this study was stored in a way that separated personal identifiers from all 
samples collected and the responses to all survey questions. Therefore, it is not possible to 
identify respondents either directly or through identifiers linked to them. 
All patients received a hardcopy of their own biochemical results. In cases of abnormal 
laboratory test results; every effort was made to refer participants to the appropriate health 
services. All the participants diagnosed with diabetes were registered free of charge to the 
nearest diabetic center of DAB and same time, all the pre-diabetes subjects were recruited in 
diabetes intervention program, a joint diabetes prevention intervention program of DAB and 
University of Oslo. 
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All procedures involving for this study were approved by National Committee for Medical and 
Health Research Ethics (NEM) of Norway and the Ethical Committee of Diabetic Association of 
Bangladesh for Medical Research. 
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Chapter 4: Results 
4.1 Demographic and socio-economic characteristics of the study population (Table 4.1 and 
Figure 4.1) 
Table 4.1: Demographic and socio-economic characteristics of the study subjects 
Variables Frequency Mean (95% CI) / Percentage 
Age Total Participants 2293 41.8 (41.2, 42.4) 
Male 842 44.3 (43.3, 45.2) 
Female 1451 40.4 (39.7, 41.1) 
Age group (year), % 20-30 548 23.9 
31-40 702 30.6 
41-50 562 24.5 
≥51 481 21.0 
Gender, % Male 842 36.7 
Female 1451 63.3 
Education, % Illiterate 1037 45.2 
Primary (0-5 class) 419 18.3 
Secondary (6-10 class) 627 27.3 
College (>10 class) & above 210 9.2 
Occupation, % Farmer 443 19.3 
Business 199 8.7 
Skill labour 112 4.8 
Manual labour 194 8.5 
Housewives  1345 58.7 
Socioeconomic 
status, % 
Low income (<6000 BDT) 953 41.6 
Middle income (6000-11000 BDT) 967 42.2 
High income (>11000 BDT) 373 16.3 
Smoking habit, % Cigarette smoking 365 15.9 
Physical activity, % Active 1946 84.9 
Inactive 347 15.1 
Calorie consumption Total calorie intake (kcal/ day) 2293 1600 (1587-1613) 
Carbohydrate (>55%) 2077 90.6 
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Protein (≥15%) 754 32.9 
Fat (>30%) 196 8.5 
 
 
 
 
The study of demographic and socio-economic characteristics is illustrated in table 4.1. The 
present analysis is based on 2,293 participants for whom all the variables were available in this 
cross sectional study. The mean age of the participants was 41.8 (95% CI; 41.2, 42.4) years. The 
participants were divided into 4 age groups with 10. Between them, 548 (23.9%) participants 
were between 25 to 30 years, 702 (30.6%) participants were between 31 to 40 years, 562 
(24.5%) were between 41 to 50 years and 481(21%) were above the age of 51 years. Among the 
total number of participants, 36.7% (n=842) were male and 63.3% (n=1451) were female 
participants. Females were younger as opposed to male subjects. A major portion of the 
participants were not educated (45.2%). Primary, secondary, college and above level 
participants were 18.3, 27.3, 9.2% accordingly. A large number of participants were housewives 
(58.7%). Among the others, there were businessmen of 8.7%, manual labor of 8.5%, farmer of 
19.3% and skill labor of 4.8%, respectively. Among them high income participants (>11000 BDT/ 
month) were 16.3% while, middle (6000-11000 BDT/month) and low income participants 
(<6000 BDT/month) were 42.2% and 41.6% respectively.  
Among the participants 15.9% and 15.1 were cigarette smokers and physically inactive 
respectively. Mean calorie consumption was 1600 Kcal/day.  90.6, 32.9 and 8.5% participants 
consumed recommended level of carbohydrate (>55%), protein (≥15%) and fat (>30%) 
respectively.   
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4.2 Clinical and biochemical characteristics of study population in both sexes (Table 4.2) 
 
Clinical and biochemical characteristics of study population in both sexes adjusted for age are 
shown in Table 4.2. Men had considerably higher mean of SBP, FPG, and TG but lower level of 
HDL-C value than women. No significant difference in the mean of LDL, 2hPG and DBP between 
men and women was found in this population. Prevalence of HTN, DM and dyslipidemia were 
15.5 % (14.1, 17.0), 7.9% (6.8, 9.0) and 28.7% (26.9, 30.5) respectively. HTN and dyslipidemia 
were significantly higher in men but no significant sex difference observed for DM. 
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Figure 4.1: Bar diagram showing age and gender wise distribution of study participants with 95% CI 
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4.3 Age specific and age standardized prevalence of different Body Mass Index (BMI) levels 
(Table 4.3 and Figure 4.2) 
Age specific and age standardized prevalence of different BMI levels are shown in Table 4.3. 
The age standardized prevalence of underweight, normal weight, overweight and obese were  
14.3%, 41.9%, 17.7%, and 26.2%, respectively. No significant sex difference observed for 
prevalence of different BMI groups. With increasing age in female, underweight group showed 
an increasing trend and the trend was statistically significance.  
 
 
Table 4.2: Clinical and biochemical characteristics of study population in both sexes 
Variables  Total (2293)  Male (842)  Female (1451)  P-value  
Male Vs Female 
SBP (mmHg) 116.2 (115.6, 116.9) 117.2 (116.2, 118.3) 115.2 (114.4, 116.1) 0.002 
DBP (mmHg) 77.1 (76.6, 77.5) 77.6 (76.9, 78.2) 76.5 (76.0, 77.1) 0.499 
Hypertension (%) 15.5 (14.1, 17.0) 17.5 (15.1, 20.0) 14.3 (12.5, 16.1) 0.034 
FPG (mmol/L) 5.2 (5.1, 5.3) 5.3 (5.2, 5.5) 5.1 (5.0, 5.2) 0.002 
2hPG (mmo/L) 6.3 (6.2, 6.4) 6.3 (6.1, 6.5) 6.2 (6.1, 6.4) 0.499 
Diabetes (%) 7.9 (6.8, 9.0) 9.1 (7.2, 11.0) 7.2 (5.8, 8.5) 0.101 
Chol (mmol/L) 4.32 (4.29, 4.36) 4.33 (4.28, 4.38) 4.32 (4.28, 4.36) 0.800 
TG* (mmol/L) 1.38 (1.35, 1.40) 1.43 (1.39, 1.48) 1.32 (1.29, 1.36) <0.001 
HDL (mmol/L) 0.90 (0.89, 0.91) 0.86 (0.84, 0.97) 0.93 (0.92, 0.94) <0.001 
LDL (mmol/L) 2.75 (2.72, 2.78) 2.74 (2.69, 2.78) 2.76 (2.72, 2.79) 0.515 
Dyslipidemia (%) 28.7 (26.9, 30.5) 35.3 (32.1, 38.5) 24.8 (22.6, 27.0) <0.001 
Data are mean (95% confidence interval) or percentage (95% confidence interval) adjusted for age as indicated. 
*Geometric mean (95% confidence interval) for triglyceride (TG). Dyslipidemia: fasting TG ≥1.7 mmol/L and high-density 
lipoproteins (HDL) <1.04 mmol/L (male), <1.29 mmol/L (female). Diabetes: diagnosed according to World Health 
Organization 1999 criteria20. Hypertension: systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 
mmHg21. 2hPG, 2-h plasma glucose; BMI, body mass index; DM, diabetes mellitus; FPG, fasting plasma glucose; WC, 
waist circumference; WHR, waist-to-hip ratio.; T-Chol; total cholesterol; LDL-C; low density lipoprotein cholesterol.   
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Table 4.3: Age specific and age standardized prevalence of  different Body Mass Index (BMI) levels 
Variables  
 
Age specific (year) prevalence, %  Age Standardized  
prevalence,  % (95% CI) 
 20-30 31-40 41-50 ≥51 20-80 years 
Underweight (BMI <18.5 Kg/m2)      
Total (n=328) 11.7 10.3 16.2 21.0  14.3 (12.9, 15.7) 
Male 14.6 9.1 14.3 18.6 13.6 (11.3, 16.0) 
Female 10.4 10.9 17.5 23.1a 14.9 (12.1, 16.8) 
Normal weight (BMI 18.5-<23 Kg/m2)      
Total (n=960) 46.2 39.2 41.1 41.8 41.9 (39.9, 43.9) 
Male 44.2 41.4 41.1 42.9 42.3 (38.9, 45.7) 
Female 47.0 38.9 41.1 40.8 41.5 (38.9, 44.1) 
Overweight (BMI 23-<25 Kg/m2)      
Total (n=405) 18.6 17.1 17.6 17.5 17.7 (16.1, 19.2) 
Male 18.8 19.8 17.9 19.9 19.1 (16.5, 21.8) 
Female 18.5 15.7 17.5 15.4 16.8 (14.9, 18.7) 
Obese (BMI ≥25 Kg/m2)      
Total (n=600) 23.7 33.5 25.1 19.8 26.2 (24.4, 27.9) 
Male 22.4 29.7 26.8 18.6 25.1 (22.1, 28.0) 
Female 24.0 35.3 23.9 20.8 26.8 (24.5, 29.0) 
Values are presented as % (number) or (95% confidence interval) as indicated. Age adjustment was based on 2001 
census of Bangladesh.  
aχ2 trend=P<0.05 for different age group. CI, confidence interval; BMI, body mass index 
 
 
 
52 
 
 
 
 
 
 
4.4 Age specific and Age adjusted mean of Body Mass Index (BMI) by different levels (Table 
4.4) 
 
Age specific and age adjusted mean of body mass index (BMI) by different levels are shown in 
Table 4.4. The age adjusted mean of underweight, normal weight, overweight, obese and 
overall were 17.1, 20.8, 23.9, 27.7 and 22.4 kg/m2 respectively. Statistically difference between 
the two sexes was noticed in the age adjusted mean of obese group (27.3 kg/m2 in male and 
27.9 kg/m2 in female; P<0.05). There was no mean difference found between the age groups in 
all the categories. 
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Table 4.4: Age specific and Age adjusted mean of Body Mass Index (BMI) by different levels 
  Age specific (year) means (95% CI)  Age adjusted  
mean (95% CI)    20-30 31-40 41-50 ≥51 
Underweight (N =328)      
Total 17.1 (16.8, 17.3) 17.5 (17.3, 17.7) 17.1 (16.9, 17.4) 16.7 (16.5, 16.9)  17.1 (16.9, 17.2) 
Male 17.0 (16.5, 17.5) 17.6 (17.2, 18.1) 17.2 (16.7, 17.7) 16.8 (16.4, 17.2) 17.1 (16.9, 17.3) 
Female 17.1 (16.8, 17.4) 17.5 (17.2, 17.7) 17.1 (16.8, 17.4) 16.7 (16.4, 17.2) 17.1 (16.9, 17.2) 
Normal weight (N=960)      
Total 20.8 (20.6, 20.9) 20.8 (20.6, 20.9) 20.9 (20.7, 21.0) 20.8 (20.6, 23.0) 20.8 (20.7, 20.9) 
Male 20.7 (20.4, 21.0) 20.8 (20.6, 21.1) 20.8 (20.5, 21.1) 20.8 (20.5, 21.0) 20.8 (20.7, 20.9) 
Female 20.8 (20.6, 21.0) 20.8 (20.6, 20.9) 20.9 (20.7, 21.1) 20.8 (20.6, 21.1) 20.8 (20.7, 20.9) 
Overweight (N=405)      
Total 23.9 (23.8, 24.1) 23.9 (23.8, 24.1) 23.9 (23.8, 24.0) 23.9 (23.8, 24.0) 23.9 (23.8, 24.0) 
Male 23.9 (23.7, 24.1) 23.9 (23.8, 24.2) 23.9 (23.8, 24.0) 23.9 (23.7, 24.0) 23.9 (23.8, 24.0) 
Female 24.0 (23.8, 24.1) 24.0 (23.8, 24.1) 23.9 (23.8, 24.1) 23.9 (23.8, 24.0) 23.9 (23.8, 24.0) 
Obese  (N=600)      
Total 27.6 (27.2, 28.0) 27.9 (27.6, 28.2) 27.6 (27.2, 28.0) 27.3 (26.8, 27.7) 27.7 (27.5, 27.9) 
Male 27.3 (26.6, 27.9) 27.3 (26.9, 27.7) 27.4 (26.7, 28.1) 27.1 (26.3, 27.8) 27.3 (27.0, 27.6) 
Female 27.3 (27.0, 28.3) 28.2 (27.8, 28.6) 27.7 (27.2, 28.2) 27.4 (26.9, 28.0) 27.9 (27.7, 28.1)
b
 
Overall (N=2293)       
Total  22.6 (22.2, 22.9)                     23.4 (23.1, 23.7)            22.5 (22.2, 22.8)              21.8 (21.4, 22.1)           22.4 (22.3, 22.5) 
Male  22.3 (21.7, 22.8)            23.1 (22.6, 23.5)            22.6 (22.1, 23.1)              21.8 (21.3, 22.3)           22.3 (22.2, 22.4) 
Female  22.7 (22.3, 23.1)            23.5 (23.2, 23.9)            22.4 (21.9, 22.8)              21.7 (21.2, 22.2)           22.4 (22.3, 22.5) 
Values are presented as mean (95% confidence interval) as indicated.  
b
P<0.05 between male and female in same group CI, confidence interval; BMI, body mass index 
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4.5 Age specific and age standardized prevalence of central obesity based on Waist 
circumference (WC) and Waist hip ratio (WHR) (Table 4.5 and Figure 4.3) 
Age specific and age standardized prevalence of central obesity based on Waist circumference 
(WC) and Waist hip ratio (WHR) are shown in Table 4.5. The age standardized prevalence of 
central obesity based on WC and WHR were 39.8% and 71.6% respectively. In age standardized 
prevalence of central obesity, both WC and WHR showed significant sex differences. The 
prevalence of central obesity by WHR demonstrated that a growing trend with increasing age in 
female and the trend was statistically significance. 
 
 
 
 
Table 4.5:  Age specific and age standardized prevalence of central obesity based on Waist circumference (WC) 
and Waist hip ratio (WHR) 
Variables  Age specific (year) prevalence, %  Age Standardized  
prevalence,  % (95% CI) 
 20-30 31-40 41-50 ≥51 20-80 years 
Central Obesity by WC (cm)      
Total (M ≥90 & F ≥80) 34.9 46.3 41.6 33.9 39.8 (37.9, 41.7) 
Male (≥90 cm) 16.4 28.9 29.9 19.9 24.3 (21.4, 27.1) 
Female (≥80 cm) 42.8 54.9 49.4 45.8 48.7 (46.2, 51.3)b 
Central Obesity by WHR       
Total (M ≥0.90 & F ≥0.80) 66.6 73.1 73.8 72.6 71.6 (69.8, 73.4) 
Male (≥0.90) 43.6 64.7 63.4 60.6 58.4 (55.2, 61.8) 
Female (≥0.80) 76.5 77.2 80.8 82.7a 79.1 (76.9, 81.1)b 
Values are presented as % (number) or (95% confidence interval) as indicated. Age adjustment was based on 2001 
census of Bangladesh.  
CI, confidence interval  
aχ2 trend=P<0.05 Central Obesity based on WC and WHR, bP<0.05 between male and female in same group 
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4.6 Age specific and age adjusted mean of waist circumference (WC) and waist hip ratio 
(WHR), by sex (Table 4.6) 
 
Age specific and age adjusted mean of waist circumference (WC) and waist hip ratio (WHR), by 
sex shown in Table 4.6. The age adjusted mean of central obesity based on WC and WHR were 
80.5 cm and 0.88 respectively. Statistically difference between the two sexes was noticed in the 
age adjusted mean of central obesity by WC (81.8 cm in male and 79.7 cm in female; P<0.05) 
and WHR (0.91 in male and 0.86 in female; P<0.05). There was statistically significant mean 
difference found between the age groups in total and female sex.  
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Figure 4.3: Age standardized prevalence of central obesity with 95% CI define by WC and WHR 
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Table 4.6:  Age specific and age adjusted mean of Waist circumference (WC) and Waist hip ratio (WHR), by sex  
Variables  Age specific (year) means, 95% CI  Age adjusted 
 20-30 31-40 41-50 ≥51 Mean (95% CI) 
Central Obesity by WC (cm)      
Both sex (M ≥90 & F ≥80) 79.2 (78.4, 80.1) 81.8 (81.6, 82.6) 81.0 (80.1, 81.8) 79.5 (78.4, 80.4)
a
 80.5 (80.1, 80.9) 
Male (≥90 cm) 80.0 (78.4, 81.5) 83.1 (81.9, 84.3) 82.8 (81.4, 84.1) 80.8 (79.4, 82.2) 81.8 (81.1, 82.5) 
Female (≥80 cm) 78.9 (77.9, 79.9) 81.2 (80.2, 82.2) 79.8 (78.7, 80.9) 78.2 (76.8, 79.7)
a
 79.7 (79.2, 80.3)
b
 
Central Obesity by WHR       
Both sex (M ≥0.90 & F ≥0.80) 0.86 (0.85, 0.87) 0.88 (0.86, 0.89) 0.89 (0.88, 0.90) 0.89 (0.88, 0.90)
a
 0.88 (0.87, 0.89) 
Male (≥0.90) 0.89 (0.87, 0.90) 0.91 (0.90, 0.92) 0.92 (0.91, 0.93) 0.91 (0.90, 0.92) 0.91 (0.90, 0.93) 
Female (≥0.80) 0.85 (0.84, 0.86) 0.86 (0.85, 0.87) 0.87 (0.86, 0.88) 0.87 (0.86, 0.88)
a
 0.86 (0.85, 0.87)
b
 
Values are presented as mean (95% confidence interval). Age adjustment was based on 2001 census of Bangladesh.  
CI, confidence interval.  
a
P<0.05 between age group: 
b
P<0.05 between male and female in same group 
                  
 
 
 
4.7 The prevalence of central obesity based on WC and WHR by BMI levels (Table 4.7 and 
Figure 4.4) 
The prevalence of central obesity based on WC and WHR significantly differed among 
categories of BMI. The prevalence of central obesity by WC and WHR were  2.4% and 36.0% for 
subjects with underweight (BMI <18.5 kg/m2), 16.4% and 64.1% for those with normal-weight 
(BMI 18.5-22.9 kg/m2), 54.3% and 87.2% for subjects with  overweight (BMI 23-24.9 kg/m2) and 
88.0% and 92.7% for obese subjects (BMI ≥25 kg/m2) respectively. 
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Table 4.7:  The prevalence of central obesity based on WC and WHR by BMI levels 
  
 
 
 
 
  Central obesity 
  WC (cm)   WHR  
BMI (Kg/m
2
) Total Number Prevalence (%, 95% CI) Number Prevalence (%, 95% CI) 
Underweight  
(BMI <18.5) 
328 8 2.4 (1.2, 4.8) 118 36.0 (31.0, 41.3) 
Normal-weight 
(BMI 18.5-22.9) 
960 157 16.4 (14.2, 18.8) 615 64.1 (60.1, 67.0) 
Overweight 
(BMI 23-24.9) 
405 220 54.3 (49.5, 59.1) 353 87.2 (83.6, 89.2) 
Obese 
(BMI ≥25) 
600 528 88.0 (85.2, 90.4) 556 92.7 (90.3, 94.5) 
Total 2293 913 39.8 1144 78.8 
p value    <0.001  <0.001 
BMI, body mass index; WC, waist circumference; WHR, waist hip ratio 
P for comparison among different BMI categories  
Figure 4.4:  The prevalence of central obesity with 95% CI based on WC and WHR by BMI levels 
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4.8 Prevalence of generalized obesity based on different BMI (kg/m2) cut-off level and their 
adjusted odds for predicting diabetes mellitus (Table 4.8 and Figure 4.5)  
Table 4.8 shows the age adjusted prevalence of generalized obesity based on different BMI cut-
off levels and their adjusted odds for estimating diabetes mellitus. The overall age adjusted 
prevalence of obesity using the WHO definition of BMI ≥30kg/m2 for western population was 
3.8%, CI: 3.0, 4.5 (women: 4.6% > men: 2.3%). However, using the BMI ≥27.5 for Asian 
population, it was 10.9%. CI: 9.6, 12.2 (women: 11.8% > men: 9.2%), at the same time as using 
cut-off levels recommended by the International Association for the Study of Obesity BMI ≥25, 
it was 26.2%, CI: 24.4–27.9 (women: 26.8% > men: 25.1%), and lastly, using the new definition 
of BMI ≥23, it was 17.7% CI: 16.1, 19.2 (women: 16.8% < men: 19.1%). The adjusted ORs was 
highest for BMI ≥25 (OR: 2.12) for predicting DM compared to other three groups.  
 
 
 
 
 
Table 4.8:  Prevalence of generalized obesity based on different BMI (kg/m2) cut-off level and their adjusted 
odds for predicting diabetes mellitus 
BMI level  Total 
N (%) 
 Diabetes  
N (%) 
 
 
Normal 
N (%) 
 
 
OR (95% CI)
e
  P value for OR 
≥23 kg/m
2
 
a
 405 (17.7) 39 (9.6) 366 (90.4)  1.26 (0.87, 1.83) 0.228 
≥25 kg/m
2
 
b
 601 (26.2)  72 (12.0) 529 (88.0)  2.12 (1.53, 2.93) <0.001 
≥27.5 kg/m
2
 
c
 250 (10.9) 31 (12.4) 219 (87.6)  1.93 (1.27, 2.94) 0.002 
≥30 kg/m
2
 
d
 86 (3.8) 10 (11.6) 76 (88.4)  1.78 (0.89, 3.53) 0.098 
BMI, body mass index; OR, odd ratio; CI, confidence interval 
A, b: overweight and obesity cut-off levels recommended by the International Association for the Study of Obesity and the 
International Obesity Task Force for Asian population (33) 
c: obesity cut-off level recommended by WHO for Asian population (33) 
d: obesity cut-off level recommended by WHO for western population (32) 
e: adjusted with age, sex, smoking and physical activity 
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4.9 Prevalence of Obesity based on different socio-demographic condition of study 
population (Table 4.9 and Figure 4.6) 
 
 
Table 4.9 shows prevalence of obesity based on different socio-demographic condition of study 
population. In education level, obesity rate was lower in college and above level than illiterate, 
primary and secondary level. Obesity rate was higher in participants belonging in high 
socioeconomic status and participants who were nonsmoker and physically inactive. 
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Figure 4.5:  Prevalence of obesity and T2DM based on different BMI levels  
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P value: within group variables 
 
 
 
 
 
 
 
 
 
 
 
Table 4.9: Prevalence of Obesity based on different socio-demographic condition of study population  
Variables  Obesity prevalence n, (%)  P value 
Education level  <0.001 
Illiterate 299 (28.8)  
Primary 120 (28.6)  
Secondary 156 (24.9)  
College & above 26 (12.4)  
Socioeconomic status  <0.001 
Low 173 (18.2)  
Medium 262 (27.1)  
High 166 (44.5)  
Smoking habits  <0.001 
No 541 (28.1)  
Yes 60 (16.4)  
Physical activity level  <0.001 
Active 489 (25.1)  
Inactive 112 (32.3)  
61 
 
 
 
 
 
 
4.10 Association between general (BMI ≥25 Kg/m2) and central obesity (WC: M ≥90 & F ≥80) 
and socio-demographic factors in the surveyed population aged ≥20 years (Table 4.10)  
 
Table 4.10 shows middle age, medium and high SES, illiterate, primary and secondary 
education, physical inactivity, high consumption of carbohydrate, protein and fat, were some 
significant risk indicators for generalized and central obesity. Additionally, females had sig-
nificant risk factor for central obesity. Smoking was protective factor for both generalized and 
central obesity. 
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Figure 4.6: Prevalence of obesity based on different socio-demographic condition of study population 
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Table 4.10:  Association between general (BMI ≥25 Kg/m
2
) and central obesity (WC: M ≥90 & F ≥80) and socio-
demographic factors in the surveyed population aged ≥20 years 
  Generalized obesity (BMI)  Central obesity (WC) 
Valuable OR 95% CI P value OR 95% CI P value 
Age (years)       
20-30  Ref   Ref   
31-40  1.63 1.25, 2.13 <0.001 1.69 1.32, 2.16 <0.001 
41-50  1.22 0.84, 1.49 0.431 1.56 1.20, 2.03 0.001 
≥51  0.75 0.54, 1.03 0.075 1.05 0.79, 1.38 0.741 
Sex       
Male Ref   Ref   
Female 1.05 0.81, 1.35 0.739 3.70 2.86, 4.79 <0.001 
Education       
Higher  Ref    Ref   
Secondary  2.34 1.49, 3.67 <0.001 2.13 1.47, 3.91 <0.001 
Primary 2.84 1.79, 4.51 <0.001 2.65 1.79, 3.91 <0.001 
Illiterate 2.87 1.86, 4.42 <0.001 3.32 2.33, 4.74 <0.001 
SES       
Low Ref   Ref   
Medium 1.69 1.35, 2.12 <0.001 1.59 1.30, 1.94 <0.001 
High 3.42 2.60, 4.50 <0.001 2.91 2.24, 3.81 <0.001 
Smoking       
No Ref   Ref    
Yes 0.48 0.34, 0.68 <0.001 0.70 0.51, 0.97 0.031 
Physical activity       
active Ref   Ref   
inactive 1.58 1.17, 2.14 0.003 1.78 1.32, 2.39 <0.001 
Carbohydrate intake (%)       
≤55% Ref   Ref   
>55% 2.78 2.00, 4.00 <0.001 2.87 2.04, 4.05 <0.001 
Protein intake (%)       
<15% Ref   Ref   
≥15% 1.25 1.01, 1.55 0.039 1.26 1.02, 1.56 0.036 
Fat intake (%)       
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<30% Ref   Ref   
≥30% 1.78 1.19, 2.65 0.005 1.78 1.19, 2.67 0.005 
Adjusted by age, sec, educational status, socioeconomic status (SES), smoking, physical activity, depression, 
carbohydrate, protein and fat intake.   
BMI, body mass index; WC, waist circumference 
 
 
 
 
4.11 The prevalence of IFG, IGT and DM by General obesity based on BMI (Table 4.11 and 
Figure 4.7) 
 
Table 4.11 shows the prevalence of IFG, IGT and DM by general obesity based on different BMI 
levels. The rates of IFG for subjects with underweight (BMI <18.5 kg/m2), normal-weight (BMI 
18.5-22.9 kg/m2), overweight (BMI 23-24.9 kg/m2) and obesity (BMI ≥ 25 kg/m2) were 3.7%, 
2.2%, 4.4% and 4.7% respectively and the prevalence rates of IGT for those four BMI categories 
were 2.4%,4.2%, 3.7% and 9.2% respectively. The rates of DM were 2.7%, 6.4%, 9.6% and 12% 
respectively for those four BMI categories.   
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Table 4.11: The prevalence of IFG, IGT and DM by General obesity based on BMI 
  
 
 
 
 
  IFG  IGT  DM 
 Total  No Prevalence  
(%, 95 CI) 
 No Prevalence 
 (%, 95% CI) 
 No Prevalence  
(%, 95% CI) 
BMI (Kg/m2)*           
Underweight  
(BMI <18.5) 
328  12 3.7 (2.1, 6.2)  8 2.4 (1.2, 4.7)  9 2.7 (1.5, 5.1) 
Normal-weight 
(BMI 18.5-22.9) 
960  21 2.2 (1.4, 3.3)  40 4.2 (3.1, 5.6)  61 6.4 (5.0, 8.1) 
Overweight 
(BMI 23-24.9) 
405  18 4.4 (2.8, 6.9)  15 3.7 (2.3, 6.0)  39 9.6 (7.1, 12.9) 
Obese 
(BMI ≥25) 
600  28 4.7 (3.3, 6.7)  55 9.2 (7.1, 11.7)  72 12 (9.6, 14.8) 
Total 2293  79 3.4 (2.8, 4.8)  118 5.1 (4.3, 6.1)  181 7.9 (6.9, 9.1) 
p value    .036   <0.001   <0.001 
IFG, impaired glucose tolerance; IGT, impaired glucose tolerance; DM, diabetes mellitus; BMI, body mass index; CI, 
confidence interval 
*Based on the diagnostic criteria for Asian population (33)  
P for comparison among different BMI categories 
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4.12:  The prevalence of IFG, IGT and DM by Central obesity based on WC and WHR (Table 4.12 and 
Figure 4.8)  
Table 4.12 shows the prevalence of IFG, IGT and DM by central obesity based on WC and WHR. 
The IFG prevalence rates for subjects with WC within the normal range and those considered 
obese were 3.0% and 4.1% respectively, whereas the IGT prevalence rates for the two groups 
were 3.5% and 7.7% respectively. The prevalence rates of DM were 5.3% and 11.8% 
respectively for the WC categories.  
The rates of IFG for subjects with WHR within the standard range   and those measured obesity 
were 2.8% and 3.7% respectively and the prevalence rates of IGT for those two WHR categories 
were 3.2% and 5.9% respectively, while the prevalence rates of DM were 2.9% and 9.9% 
respectively for those two WHR categories.  
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Figure 4.7: The prevalence of IFG, IGT and DM by General obesity (with 95% CI) based on BMI 
66 
 
 
 
 
 
 
 
 
 
 
 
Table 4.12:  The prevalence of IFG, IGT and DM by Central obesity based on WC and WHR 
  
 
 
 
 
  IFG   IGT   DM  
 Total No Prevalence (%) No Prevalence (%) No Prevalence (%) 
WC (cm)*        
Normal 
(M <90 & F <80) 
1380 42 3.0 (2.3, 4.1) 48 3.5 (2.6, 4.6) 73 5.3 (4.2, 6.6) 
Obese 
(M ≥90 & F ≥80) 
913 37 4.1 (3.0, 5.5) 70 7.7 (6.1, 9.6) 108 11.8 (9.9, 14.1) 
Total 2293 79 3.4 (2.8, 4.3) 118 5.1 (4.3, 6.1)  181 7.9 (6.9, 9.1) 
P value   0.195  <0.001  <0.001 
WHR*        
Normal 
(M <.90 & F <.80) 
651 18 2.8 (1.8, 4.3) 21 3.2 (2.1, 4.9) 19 2.9 (1.9, 4.5) 
Obese 
(M ≥.90 & F ≥.80) 
1642 61 3.7 (2.9, 4.7) 97 5.9 (4.9, 7.2) 162 9.9 (8.5, 11.4) 
Total 2293 79 3.4 (2.8, 4.3) 118 5.1 (4.3, 6.1) 181 7.9 (6.9, 9.1) 
P value   0.318  <0.012  <0.001 
IFG, impaired glucose tolerance; IGT, impaired glucose tolerance; DM, diabetes mellitus; WC, waist circumference; WHR, 
waist hip ratio; M, male; F, female 
*Based on the diagnostic criteria for Asian population (33)   
P for comparisons among different  categories of WC and WHR, respectively  
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4.13 Anthropometric characteristics by sex and diabetes status are demonstrated (Table 4.13 and 
Figure 4.9) 
Anthropometric characteristics by sex and diabetes status are demonstrated in Table 4.13. Both 
males and females with DM had a significantly greater mean weight, BMI, WC and WHR. 
Additionally, in both sexes, study subjects with DM had higher rate of general obesity (defined 
by BMI) and central obesity (defined by WC and WHR) than non DM subjects.  
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Figure 4.8:  The prevalence of IFG, IGT and DM by Central obesity (with 95% CI) based on WC and WHR 
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Table 4.13:  Anthropometric characteristics of study population by sex and diabetes status  
  Men (842)  Women (1451) 
 No diabetes Diabetes  P value  No diabetes  Diabetes  P value 
Number  762 80 (9.5%)  1350 101 (7.0%)  
Weight (kg) 58.5 (57.8, 59.3) 62.3 (60.2, 64.4) 0.001 50.9 (50.4, 51.5) 55.7 (53.9, 57.4) <0.001 
Height (m) 1.616 (1.612, 1.621) 1.623 (1.611, 1.635) 0.310 1.501 (1.498, 1.504) 1.506 (1.496, 1.517) 0.294 
BMI (kg/m
2
) 22.4 (22.1, 22.6) 23.6 (22.9, 24.3) 0.001 22.6 (22.4, 22.8) 24.5 (23.8, 25.2) <0.001 
BMI (≥25kg/m
2
), % 23.7 (20.7, 26.7) 34.2 (23.7, 44.7) 0.037 25.7 (23.3, 28.0) 46.4 (36.6, 56.1) <0.001 
WC (cm) 81.2 (80.5, 81.9) 86.5 (84.5, 88.4) <0.001 79.2 (78.6, 79.8) 86.2 (84.3, 88.1) <0.001 
WC (M ≥90 cm; F ≥80 cm), % 22.6 (19.7, 25.6) 40.8 (30.0, 51.7) <0.001 46.8 (44.1, 49.5) 75.3 (66.9, 83.7) <0.001 
WHR  0.91 (0.90, 0.92) 0.94 (0.93, 0.95) <0.001 0.86 (0.85, 0.87) 0.92 (0.90, 0.93) <0.001 
WHR (M≥0.90; F≥0.80), % 56.8 (53.3, 60.3) 82.0 (73.5, 90.6) <0.001 77.7 (75.4, 79.9) 94.9 (90.6, 99.3) <0.001 
Data are mean (95% confidence interval) or percentage (95% confidence interval) adjusted for age as indicated 
BMI: body mass index; WC: waist circumference; WHR: waist to hip ratio 
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Figure 4.9: Prevalence of general and central obesity with 95% CI of study population by sex and 
diabetes status 
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4.14 Receiver operator curve characteristics for anthropometric variables in predicting diabetes (DM) 
and cut-off points for maximum sum of sensitivity and specificity in men and women (Table 4.14 and 
Figure 4.10)   
 
Receiver operator curve (ROC) analysis was adapted to compare the diagnostic performance of 
the anthropometric indices to predict the presence of DM and to find out the optimal cut-off 
points for each index. These are presented in Table 4.14 and Fig. 4.10. ROC analysis showed the 
optimal cut-off points for DM detection were at a BMI of 21.2 kg/m2 in men and 21.8 kg/m2 in 
women, WC 82 cm in men and women and WHR 0.93 and 0.87 respectively. In spite of gender 
differences, WHR had the highest diagnostic values for the detection of DM in both sexes when 
compared with BMI and WC. Further, the AUC for both central obesity indices were notably 
higher than for BMI. The area under the ROC for WHR was larger than those of the other 
indices. 
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Table 4.14  Receiver operator curve characteristics for anthropometric variables in predicting diabetes (DM) and cut-off points for maximum sum of 
sensitivity and specificity in men and women 
 Men  
 
Women 
 AUC  
(95% CI) 
Cut-off  
point 
Sensitivity  
(%) 
Specificity  
(%) 
AUC 
(95% CI) 
Cut-off  
point 
Sensitivity  
(%) 
Specificity  
(%) 
BMI (kg/m
2
) 0.62 (0.56, 0.68) 21.2 82.5 41.2 0.65 (0.60, 0.71) 21.8 77.2 46.5 
WC (cm) 0.67 (0.61, 0.73) 82.0 76.2 53.7 0.70 (0.65, 0.75) 82.0 67.3 62.5 
WHR 0.69 (0.63, 0.75) 0.93 68.8 60.9 0.73 (0.68, 0.78) 0.87 84.2 54.5 
AUC: area under the receiver operating characteristic curve; BMI: Body mass index; WC: waist circumference; WHR: waist hip ratio. Comparison among 
anthropometric variables for predicting DM in men: BMI vs WC: χ
2
 = 9.23, p=0.002; BMI vs WHR: χ2 = 6.23, p=0.01; WC vs WHR. Comparison among 
anthropometric variables for predicting DM in women: BMI vs WC: χ2 = 10.51, p=0.001; BMI vs WHR: χ2 = 8.33, p=0.003; WC vs WHR: χ2 = 3.52, p=0.06. 
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Figure 4.10: ROC (receiver operating characteristics) curve for body mass index (BMI), waist 
circumference (WC) and waist hip ratio (WHR) to predict diabetes mellitus (DM) by for men and women.  
 
 
4.15 Unadjusted and adjusted odd ratios (ORs) of anthropometric indices for predicting DM 
(Table 4.15 and Figure 4.11)   
 
Table 4.15 summarizes the independent relationships between the three anthropometric 
indices and the relative risk of having DM using both univariate and multiple logistic regression 
analysis after adjustment for age, social class, cigarette smoking and physical activity. The 
anthropometric indices, except for BMI, conferred a significant risk of DM in both unadjusted 
and adjusted models in men. WC and WHR were significantly associated with a 2- to 3-fold 
increase in risk for DM. Likewise all three obesity indices were significantly associated with DM, 
with a 2- to 5-fold increased risk in women. The unadjusted odds ratios for WHR and the 
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presence of DM were higher than in the other indices, statistically significant p < 0.001, and 
greater in women 5.53 (2.23, 13.72) than men 3.60 (1.99, 6.52). After controlling for covariates 
using logistic regression analysis, the adjusted odds ratio in women 5.35 (2.15, 13.27), men 3.21 
(1.76, 5.84) was only a little reduced and remained statistically significant p < 0.001 with 
positive associations greater in women.  
 
 
 
 
 
 
 
Table 4.15 Unadjusted and adjusted odd ratios (ORs) of anthropometric indices for predicting DM 
  Unadjusted  
OR (95% CI) 
P value          Adjusted   
OR (95% CI) 
P value 
Men     
BMI (≥25 kg/m
2
) 1.53 (0.93, 2.52) 0.091 1.50 (0.91, 2.51) 0.113 
WC (≥90 cm) 2.27 (1.40, 3.66) 0.001 2.09 (1.28, 3.41) 0.003 
WHR (≥0.90) 3.60 (1.99, 6.52) <0.001 3.21 (1.76, 5.84) <0.001 
Women 
BMI (≥25 kg/m
2
)  2.42 (1.60, 3.64) <0.001  2.48 (1.63, 3.76) <0.001 
WC (≥80 cm) 3.45 (2.17, 5.49) <0.001 3.47 (2.18, 5.53) <0.001 
WHR (≥0.80) 5.53 (2.23, 13.72) <0.001 5.35 (2.15, 13.27) <0.001 
DM: diabetes mellitus; CI: confidence interval; BMI: body mass index; WC: waist circumference; WHR: waist 
hip ratio; after univariate logistic regression. Adjusted odds ratio after logistic regression analysis adjusted for 
age group (20-30, 31-40, 41-50 & ≥51), social class, cigarette smoking & physical activity. 
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Figure 4.11: Adjusted odd ratios (ORs) of anthropometric indices for predicting DM by sex 
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Chapter 5: Discussion 
 
5.1 Methodological Issues  
 
5.1.1 Appropriateness of Study Design  
Obesity is a growing public health concern in developing world. It is a common risk factor of 
major cardiometabolic diseases including T2DM, HTN, coronary artery disease etc. Primary 
objective of the study was to establish the prevalence of obesity in rural population of 
Bangladesh, where previous population based data do not exist following new Asian 
classification. Obesity, being frequent and long duration, was measured appropriately using 
cross-sectional study design. Another aims of study was to investigate the causative factors of 
obesity and its association with diabetes. To investigate the risk factors that may be associated 
with the occurrence and increment of obesity, cross-sectional studies are not the adequate 
methods to investigate causation. Since exposure and outcome are measured at the same time 
in a cross-sectional design, it is not possible to determine whether the described exposure 
preceded the disease or disease resulted from the exposure. However, the pathophysiological 
mechanism of causation of obesity and diabetes has been well workout, and findings from 
prospective studies were used to assist in the analysis and interpretation of results in cross 
sectional studies. Moreover, short duration of study period and limited budget are other 
reasons for selecting cross-sectional design.  
 
5.1.2 Validity of Statistical Association  
 
5.1.2.1 Samples size  
The size of the sample of the population in a study is one of the main concerns in determining 
whether an observed association between exposure and outcome is due to chance alone. Small 
sample size than the required numbers may lead to β-error (we do not observe the association 
where there is an association). Furthermore, smaller sample size, is less likely to be 
representative of the population from where the sample is drawn. In 2009 study, around 3000 
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randomly selected individuals were invited to participate in the study. In order to determine 
required sample size for this study, the Student’s formula was used.  
n= Z2PQ/d2,  
where, Z=1.96, P for prevalence (DM & impaired glucose regulation) rural area from the 
previous study i.e. 0.20; Q = 1-P i.e. 0.80 and d= allowable error of known prevalence i.e. 0.07 x 
0.20. Ideally, it should be 0.05 x 0.20; but, to be on safe estimation with minimum sample size 
we allowed only 7% (or .06) error of prevalence.  
Thus, n = (1.96)2 (0.20)(0.80) / [(0.07)(0.20)]2  
Or, 0.614656/ 0.000196 = 3,136.  
 
5.1.3 Bias  
 
5.1.3.1 Selection bias  
Selection bias refers to systematic errors in procedures that are used to select study 
populations or the factors that might influence participation in the study; therefore there is a 
systematic error in the identification of the study population. A low response rate could 
introduce selection bias, especially if the person responding or avoiding in participation in the 
study that have special characteristics which are associated with the exposure and outcomes 
measured.  
In this study selection bias was not a major concern because the high response rate of both 
men and women.  
 
5.1.3.2 Information bias  
Information bias refers to methodical errors in the information obtained from the participants. 
These errors could be due to differences in the ways in which the interviewers or data 
collectors obtain information from the participants or to the participants themselves reporting 
information in a non- comparable way.  
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To avoid information biases related to the collection of socio-demographic data, well-trained 
interviewers from the local community were employed to conduct a reliable interview 
administering the questionnaire.  
 
5.1.3.3 Measurement bias  
Measurement bias occurs when the individual measurements or classification of disease or 
exposure are inaccurate, that is they do not measure correctly what they are supposed to 
measure. There are many sources of measurement bias and their effects are of varying 
importance. Biochemical and biophysical measurements are never completely accurate and 
different methods of investigation often produce different results on the same individual.  
To avoid the measurement bias, all anthropometrical measurements including height, weight, 
waist and hip circumference were measured by the trained interviewers. For measuring weight, 
weight scales was standardized by measuring his/her own weight every day morning and were 
checked after every 20 patients and was calibrated. The anthropometries were recruited from 
the BIRDEM Hospital in Dhaka. He/she is trained and performs these measures as an everyday 
business.  
Blood pressure was measured by the physician on the right arm using normal cuffs for adult 
fitted with a standard sphygmomanometer. The machine was checked every day before 
starting the measurement.  
Quality control on the blood glucose measurement was checked by measuring the 2-hour 
plasma glucose values using the glucose oxidase methods in every 10th case.  
 
5.1.4 Confounding  
Confounding refers to a distortion of the estimated effect of an exposure on an outcome, 
caused by the presence of an extraneous factor associated both with the exposure and the 
outcome. In this study control of confounding was done by random selection of study subjects 
and effect of age in the prevalence of obesity and diabetes was minimized by stratification. The 
strength of individual risk from other confounders was controlled in multivariate analysis by 
logistic regression analysis.  
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5.1.5 Generalizability  
 
The rural area was selected for this study. It should be noted that 72% of the Bangladesh 
population live in rural areas and the demographic of which is similar to the rest of the country. 
The entire populations (other than 2% tribal population) belong to the same ethnic group and 
speak the same language. Therefore it could be applicable to the whole of Bangladesh. 
Nevertheless, we find comparable socio-demographic data for the rest of rural Bangladesh. 
Therefore, we believe that the data should be interpreted with caution but we have valid 
reasons to believe that the samples should have a fair representation for the rural Bangladesh. 
Moreover, the study was conducted in a reasonable large sample population.  
 
5.2 Strengths of the study  
 
1. It is a large scale population based study.  
2. The samples were recruited randomly.  
3. More than 72% of the population in Bangladesh is living in the rural areas. Therefore, the 
population is likely to be representative.  
4. All the investigators, clinicians, anthropometrics and bio-technicians were recruited from the 
diabetic hospital of Bangladesh (BIRDEM), who was highly experienced.  
5. All laboratory analysis was performed in the BIRDEM laboratory facilities, which has the 
highest credibility within the country.  
6. The village leaders were included in the primary phase to avoid any selection bias and the 
local volunteers were recruited from the local communities to avoid any social or linguistic 
barrier.  
7. Explore and compare the predictive abilities anthropometric indices including BMI, WC and 
WHR, for the presence T2DM. Study also explores optimal cut-off levels of these indices for 
predicting the T2DM. 
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5.3 Limitations of the study  
1. This was a cross-sectional study, in epidemiological research cross-sectional study describes 
the exposure and outcomes at a time. In this study we estimated the prevalence of obesity and 
its risk indicators simultaneously. Therefore, we cannot say the identified risk factors are 
causally associated with obesity and its association with T2DM in our population.  
2. This study was conducted in selected rural areas of Bangladesh. Therefore, the results may 
be interpreted with caution.  
3. The anthropometric measurements were done once and thereby one cannot exclude the 
possibility for certain error since this was not controlled by a second observer.  
4. The blood pressure was measured twice on an individual, but it could be ideal if we 
measured three times and took the average value.  
5. AUCs of ROC analyses were not adjusted by age in the present study. Therefore, the 
relationship between each anthropometric measure and T2DM might be confounded by the 
influence of aging, underestimating the actual predictive value calculated in ROC analysis 
 
5.4. Discussion on the main findings: 
Obesity has become a major public health concern because of its adverse health consequences. 
Obesity most likely results from an interaction of genes and lifestyle factors. Although there are 
very few studies available from Asian Indians, no published information is available on the 
prevalence of obesity in rural Bangladeshi population. The present study was undertaken to 
explore prevalence of obesity, its associated risks and link with T2DM in rural Bangladeshi 
population aged ≥ 20 years.  
 
Prevalence of Obesity: 
Age specific and age standardized prevalence of overweight and obesity was 17.7% and 26.2% 
based on Asian specific cut-off levels of BMI. The prevalence of obesity documented in this 
study was comparatively higher than previous studies in Bangladesh conducted in different 
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time points using different anthropometric cut-off levels (26-28). Prevalence rate in our study 
was found higher than rural areas of China (1.7%), Greece (10.0%) and north India (8%) (132- 
134); however, they used WHO cut-off levels for western population. 
In our study, prevalence of overweight and obesity were 19.1 and 25.1% in men and 16.8 and 
26.8% in women; however in Chinese rural population, prevalence of overweight and obesity 
were 15.1% and 1.2% in men, and 22.1% and 2.2% in women (132). A study on a rural Pakistani 
population demonstrated that obesity levels among men and women were 19.5% and 24.7%, 
respectively (135). In a recent study on rural population of Tamilnadu (South India) using Asian 
cut-offs for obesity was reported to be as high as 32.2% in males and 38.2% in females (136). 
Study have shown that in countries with relatively low gross national product, the prevalence is 
~1.5–2 times higher among women than men whereas, in the developed countries, the 
prevalence of obesity is high in both men and women (137). In our study, the prevalence of 
obesity is slightly higher in women than men, while overweight is more prevalent in men. Our 
findings is also in accordance with the findings of a study conducted in Ghana where prevalence 
of obesity was found to be higher among women (7.4%) than men (2.8%) (138). In Chinese rural 
study, a significantly high prevalence of overweight and obesity was observed in women than 
men. However, in Japan, men were more likely than women to be obese (139). The observe 
difference between genders could be explained due to differences in lifestyle and 
socioeconomic status, as well as involvement of genetic or other behavioral factors. 
In our study the prevalence of obesity in both men and women gradually decreased after 50 
years but the prevalence of overweight had no obvious age differences. On the other hand, in 
Chinese rural study, considerable age-differences were also observed. As age increased, the 
prevalence of overweight decreased in men; however, the prevalence in women gradually 
decreased after 45 years of age. The prevalence of obesity had no obvious age differences 
(132). 
We have seen in South Asian study that the highest prevalence of obesity is observed in the 
middle aged (30-50 years) group, whereas in the UK prevalence tends to increase progressively 
with age (up to 64 years) (140). In our study, the highest prevalence is reached in the middle-
aged (30-40 years) group. 
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Our data show that the age standardized prevalence of central obesity based on WC (male ≥90 
cm and women ≥80 cm) and WHR (male ≥0.90 cm and women ≥0.80 cm) was 39.8% and 71.6% 
for the study population.  In the present analysis, more women had central obesity than men, 
as defined by the IDF for the Asian population (45). This might be a consequence of the division 
of labor by sex in this community. Manual labor is sustained by male physical labor. The age-
standardized prevalence of central obesity based on WC and WHR in the present study was 
24.3%, 58.4% in men and 48.7%, 79.1% in women respectively. In southern part of India 
(Tamilnadu), prevalence rates of abdominal obesity, using Asian cut-offs, was present in 17.6% 
men and 23.7% women (136).  
In this study, the prevalence rate of central obesity based on WC and WHR by BMI levels was 
39.8% and 78.8% for the total study population, 54.3% and 87.2% for those with high BMI (23-
24.9 kg/m2) and 88.0% and 92.7% for subjects considered obese with BMI ≥25 kg/m2. In 
Chinese Study, the prevalence rate of central obesity based on WC was 33.97% for the total 
study population; 63.79% and 95.95% respectively for subjects with high BMI and those 
considered obese (141). In Indian urban study, it was 32.6 and 43.3% for men and women, 
respectively (142). 
 
Prevalence of generalized obesity and their adjusted odds for predicting DM 
 
The overall age adjusted prevalence rate of generalized obesity in this study was 3.8% using 
BMI ≥30; 10.9% using BMI ≥27.5; 26.2% using BMI ≥25; and 17.7% using BMI ≥23kg/m2. We 
have found that the adjusted ORs were highest for BMI≥ 25 for predicting DM compared to 
other three groups. The age-standardized prevalence rate of generalized obesity in urban South 
Indians study was 4% using BMI ≥30; 9.9% using BMI ≥27.5; 26.5% using BMI ≥25; and 45.9% 
using BMI ≥23kg/m2 (142). This is quite similar to figures reported from other Asian countries. 
The Chinese National Nutrition Survey showed that the prevalence of obesity (BMI ≥25) was 
17.2% in Shanghai, 26.5% in Tianjin and 32.8% in Beijing (143). Using BMI ≥30, the prevalence 
of obesity among Hong Kong Chinese population was 2.2% in men and 4.8% in women, while 
using a cut point of BMI ≥27 in men and ≥25 in women, the prevalence was 10% in men and 
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27.9% in women (144). In Malaysia, the prevalence of obesity using BMI (25–30) was 24% in 
men and 18.1% in women, while using BMI≥30; it was 4.7% in men and 7.7% in women (145). In 
Thailand, the prevalence of obesity was 16.7% using the cut point of BMI 25–30 and 4% using 
BMI ≥30 (146). From the aforementioned information’s we can understand that the prevalence 
of generalized obesity can be differ in the same population depending on the cut point used. It 
is therefore clear that defining obesity either by BMI or WC/WHR is purely arbitrary. Thus data 
from different ethnic groups using different obesity cut points should be interpreted with 
cautions.  
 
Associated factors of obesity 
Studies demonstrated that high prevalence of obesity was positively associated with female 
sex, middle age, higher educational and economic status, physical inactivity and some dietary 
habits in south Asian region (147). For instance, we have seen similar findings in our study 
except education level. Middle age, medium and high SES, physical inactivity, high intake of 
carbohydrate, protein and fat, were significant risk indicators for generalized and central 
obesity and in addition, females were significant risk indicators for central obesity. However, 
smoking was protective factor for both generalized and central obesity. Increased availability of 
energy-dense foods, excess carbohydrate based diet; physical inactivity may lead to weight gain 
and subsequently obesity in our population. Similarly, in China rural study showed that women 
were at greater risk of developing obesity as opposed to men. However, Chinese people with 
higher levels of education more likely became obese compared with those with low education. 
No group difference was observed with regard to the smoking status and age factor. Moderate 
physical activity was a protective factor when compared with low physical activity (132). 
 
Prevalence of IFG, IGT and DM by general and central obesity 
Based on our results it appears that the overall prevalence rate of IFG, IGT and DM by general 
obesity were 3.4%, 5.1% and 7.9% respectively. The rates of IFG, IGT and DM were found more 
among the obese (BMI ≥25 kg/m2) group. The overall prevalence rates of IFG, IGT and DM by 
central obesity based on WC were 3.4%, 5.1% and 7.9% respectively. The IFG, IGT and DM 
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prevalence rates were higher for subject’s considered obese. The rates of IFG, IGT and DM were 
more among the subjects measured obese based on WHR. Similar findings were observed in 
InterASIA study. The overall prevalence rates for IFG and DM were 7.34% and 5.51%, 
respectively in Chinese population (141). The IFG prevalence rates for subjects with WC within 
the normal range and those considered obese were 5.96% and 10.04%, respectively, whereas 
the DM prevalence rates for the two groups were 3.95% and 8.54%, respectively (141). 
Our study showed that both men and women with DM had a significantly greater mean weight, 
BMI, WC and WHR. In addition, in both sexes, study subjects with DM had higher rate of 
general obesity (defined by BMI) and central obesity (defined by WC and WHR) compared to 
non DM subjects. 
 
Compare the diagnostic performance of anthropometric indices for predicting DM and 
determining the optimal cut-off points for each index.  
 
This is one of the few studies in the south Asian region to evaluate and compare the predictive 
ability of anthropometric indices of obesity and also define the optimal cut-off values of BMI, 
WC, and WHR for predicting diabetes in rural Bangladesh.  Study findings support that each 
central obesity indicator, WC and WHR, is strongly and independently predicted risk of diabetes 
in both gender compared to general obesity as measured by BMI. In the Asian population, this 
has been verified by a number of studies as well as pathophysiological mechanism of diabetes. 
Based on prospective and cross-sectional studies, BMI, WC, WHR have each been identified as 
an independent risk factor for DM in the Bangladeshi populations studied. Previous reports 
have also shown that central obesity is a stronger predictor of the development of DM in 
Bangladeshi study subjects (59, 114-116). It has been shown that central obesity plays a vital 
role in the pathogenesis of insulin resistance (148), increased plasma leptin, low plasma 
adiponectin (149) and stimulation of inflammatory cytokines (150). All of these factors lead to 
development of diabetes and other cardiovascular diseases. 
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The optimal cut-off values in this study for BMI were 21.2 kg/m2 for men and 21.8 kg/m2 for 
women to predict diabetes which also evident in previous studies in Bangladesh. These values 
are lower than the values recommended for western populations, (BMI ≥25 kg/m2 for 
overweight and BMI ≥30 kg/m2 for obesity), and, for Asia-Pacific populations (33,107) (BMI ≥23 
kg/m2 for overweight and, BMI ≥25 kg/m2 for obesity). Our optimal value of 82 cm for WC in 
both men and women is lower than the cut-off levels recommended by IDF for Asian 
populations (45). In contrast, IDF values are lower for WHR than our results for a WHR of 0.93 
for men and 0.87 for women in this study. In the present study, it was confirmed that the WHR, 
a measure indicative of central obesity, is a most sensitive risk indicator of DM in both sexes 
which was also marked in previous studies in Bangladesh (59,115). The observations from 
INTERHEART study indicate that WHR shows strongest association with cardiovascular risk 
(myocardial infarction) compared with BMI or WC across 52 populations from every continent 
(113). Study in India showed that abdominal obesity based on WC is a better predictor of DM 
compared to WHR (151). 
Both the odds ratios (ORs) and AUC values for BMI, WC, and WHR were higher for women than 
for men for diabetes. Our findings related to AUC were similar to the recent meta-analysis con-
ducted by Lee et al. (109) and Dong et al (152). Unadjusted and adjusted odds ratios were very 
similar in our study which suggested that these indices were independent risk factors. 
The Thai study revealed that WC and WHR were more strongly associated with diabetes than 
were weight and BMI (153). The InterASIA study analyzed that central obesity was more closely 
related to diabetes than was overall obesity and also demonstrated that both WHR and WC 
were equally important for predicting DM and IFG in the Chinese population (141). 
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Chapter 6: Conclusions, Recommendations and Future Research Implication: 
 
6.1 Conclusions 
The prevention and control of obesity in developing countries need urgent attention since the 
disease is expected to double in these countries in the next 20 to 25 years. The burden of 
obesity in Bangladesh is also increasing rapidly as like as the whole world. From the perspective 
of Bangladesh overweight and obesity can be turn into big social issue. As the problem of 
obesity has increased substantially in the past decade, there is an urgent need for a national 
strategy for health promotion towards the reduction of overweight and obesity among the 
Bangladeshi people. The age standardized prevalence of overweight and obese based on BMI 
were   17.7%, and 26.2%, respectively and central obesity based on WC and WHR were 39.8% 
and 71.6% respectively. The result also shows that prevalence of central obesity was more in 
female than male. Study shows middle age, medium and high SES, primary, secondary and 
higher education, physical inactivity, high consumption of carbohydrate, protein and fat, were 
some significant risk indicators for generalized and central obesity. Study also indicated that 
indices of central obesity predicted better cardiometabolic risk factors than general obesity 
defined by BMI for both men and women.  
Government and also related authorities need to plan about the awareness program in 
different areas of our country for preventing the obesity and its related cardiometabolic 
diseases. More large scale studies with control populations including all the possible influences 
are required to confirm our findings. 
 
6.2 Recommendations 
The results presented in this study generated several issues that warrant further evaluation. In 
a developing society like Bangladesh, where the resources are really limited relative to its 
population size, the increasing life expectancy and elevated prevalence of obesity and many 
others chronic disease like diabetes will dramatically raise the disease burden and expenses of 
the health care system. In order to prevent this burden the community needs to be mobilized. 
So everybody needs to be aware of the risk factors. 
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In order to address this issue large-scale cohort studies are needed with a control population. 
As this is the first report from Bangladesh concerning obesity in adult Bangladeshi, our results 
need to be confirmed through studies performed in different regions in Bangladesh at regular 
intervals in order to be able to assess the probable rate of increase prevalence so that an 
effective obesity prevention program can be introduced for reducing obesity burden. Additional 
obesity prevalence surveys should be carried out in different socioeconomic classes in 
Bangladesh at regular intervals in order to be able to assess the probable rate of increases 
obesity. Also, public health intervention should be focused on the control and prevention of 
obesity in children through an integrated community approach.  Some recommendations: 
 There is need to develop a community based program, which would aim at minimizing the 
risk factors of obesity. This program should promote the prevention of obesity by providing 
culturally sensitive educational messages. Health education activities included healthy life 
styles like proper diet (avoidance of high calorie food, high intake of fat etc), regular 
physical activity more than 30 minutes per day on all days of week. Established principles 
and practices of health and general education should also be included in a community 
based program. 
 Mass screening programs for the whole population in the communities with the help of 
Government and non-government agencies (NGO’s) should be carried out regularly to 
detect pre-obese and obese people in the community. Training of paramedical personnel 
and health workers regarding assessment of obesity should also be undertaken. By holding 
camps in rural areas, population at periphery and at distant places can be made aware 
about obesity, its causes, consequences and prevention. 
 Primordial prevention is an important level in prevention of obesity and other non- 
communicable diseases. This can be achieved by inculcating healthy habits in the younger 
population, as risk of obesity is to originate in the childhood. And hence primordial 
prevention related health education activities should be regularly conducted as a part of 
school and college health services involving active participation of teachers to prevent 
emergence of risk factors for obesity and other non-communicable diseases. 
 The food industry can play a significant role in promoting healthy diets by: 
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 reducing the fat, sugar and salt content of processed foods; 
 ensuring that healthy and nutritious choices are available and affordable to all 
consumers; 
 practicing responsible marketing especially those aimed at children and teenagers; 
 ensuring the availability of healthy food choices and supporting regular physical activity 
practice in the workplace. 
 
6.3 Future Research Implications 
In a setting with limited health and financial resources, and in a situation where lifestyles 
appear to be changing in unhealthy directions, the findings of high prevalence of obesity make 
primary prevention of the obvious strategy of choice. Much needs to be done on the different 
fronts of the policy making, program implementation, and research. In the area of research, this 
study points to the following needs: 
 
1. The present study will provide baseline data regarding the prevalence and risk factors of 
both general and central obesity in adult Bangladeshi population. 
2. The present study will provide baseline data regarding the association of obesity and T2DM 
in adult Bangladeshi population. 
3. This study findings will help to create baseline information’s for future cohort study.  
4. Help to generating hypothesis. 
5. The results of the current study may lay the foundation of awareness to develop policies in 
order to address the challenges to prevent overweight and obesity.  
6. Necessary data for “Global atlas on diabetes” 
7. Provide baseline information regarding identification of suitable anthropometric indices for 
predicting Type 2 diabetes for adult Bangladeshi population 
8. Provide baseline information regarding Identify the optimal cut-off values of 
anthropometric indices for defining general and central obesity suitable for Bangladeshi 
population for future cohort study. 
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Chandra Rural Diabetes Study 
A joint research program of Diabetic Association of Bangladesh and University of Oslo 
 
Know and Inform 
 
Like all other countries Diabetes and associated risk of Stroke, Heart Disease, Blindness, Kidney Failure 
and Leg Amputation is increasing in Bangladesh. Diabetes Association of Bangladesh and University of 
Oslo jointly organize a free screening program in your locality. We are inviting you to come and check 
your condition.  
Who will join? 
1. Age ≥20 years 
2. Resident of this area 
3. Not pregnant or not conceive  
4. Not suffering from any acute or chronic disease 
What will happen at the study site? 
First: - Appointment will be made beforehand with all the participants in the study by fieldworkers, in 
order to guarantee the most appropriate time for each participant.  
Second: - At the study site, the participant will be registered and will go through the following steps: 
1. A rapid blood test in fasting state (FPG) followed by drinking a glucose solution for persons who 
are not diagnosed with diabetes previously. After 2 hours of glucose drink another blood test 
will be performed.  
2. Measurement of blood pressure, height, weight, and other body measurements 
3. Filling out a health related questionnaire 
4. Total 11 ml (2 and half tea spoon) blood will be drawn for the following tests: 
 Fasting and 2-h plasma glucose 
 HbA1c (average blood glucose for last 3 months)  
 Fasting lipids (Total cholesterol, LDL, HDL and Triglycerides) 
 Serum insulin 
Who will collect your blood? 
Trained phlebotomists from Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine 
and Metabolic Disorders (BIRDEM) Hospital will collect your blood samples.  
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Where will be the blood test analysed? 
All the blood test will be sent to BIRDEM hospital for analysis. 
When will participants receive the test results? 
You can come to the study site within a week of taking the blood sample to receive the results. Test 
results that have not been claimed will be distributed to each participant at the end of the study. 
How will be the results handled?  
Results will be handled with complete confidentiality, as sample will be sent to the laboratory with a 
special number (a code) given to each participants. 
What will happen to found to have diabetes or pre-diabetes people? 
 Pre-diabetes: will be enrolled at free Diabetes Prevention Program, a joint diabetes prevention 
program of UIO and DAB. 
 Diabetes: will be registered at free of cost in the nearest diabetes centre (Chandra Diabetes 
Centre, Gazipur) for further follow-ups. 
 
To participate in the study, please make an appointment with fieldworkers and follow the instructions 
provided in the attached personal invitation. 
We welcome you at study site for any questions or clarifications 
 
With Regards, 
Coordinator 
Chandra Rural Diabetes Study Program 
Diabetic Association of Bangladesh 
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Chandra Rural Diabetes Study 
A joint research program of Diabetic Association of Bangladesh and University of Oslo 
 
Personal Invitation Letter 
 
 
Dear Mr/Mrs…………………………….. 
Greetings, 
We would like to remind you of the importance of presenting at the site of Chandra Rural Study Project 
that is administered by the Diabetic Association of Bangladesh and University of Oslo, Norway. Please be 
attendance on (day)…….(date)…….(hour)…… in order to proceed with the steps of the field investigation. 
We would also like to remind you of the importance of adhering strictly to the appointment and to the 
following guidelines: 
1. Abstaining from all kinds of food and drinks with the exception of water 12 hours before coming 
to the research site. 
2. Adhering to the day and time that will be given to you by the research team. 
3. If you are on any kind of medications and prescription (s) of recently visited physician (s), please 
bring them with you to the screening site to show to the investigating team.  
4. Please bring your national identification card when coming to the site. 
 
We thank you for your participants…… 
With Regards, 
Coordinator 
Chandra Rural Diabetes Study Program 
Diabetic Association of Bangladesh 
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Appendix III: Consent Form 
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Informed consent from 
 
You are being invited to participate in a Diabetes Research study. This form is designed to provide you with 
information about the study. The investigators or representative describes this study to you and answer any of 
your questions.    
Title of project: “Ten Years Follow-up for Diabetes in Indian-Asian Population: A Study from Bangladesh” 
 
Investigator (s):………………………………………………………………….. 
 
Address: ………………………………………………………………………… 
 
Phone No:………………………………………….  Co-Investigator (s):……………….………………. 
 
This is to certify that I, ………………………………………………………., hereby agree to participate as a volunteer in an 
authorized research project. 
 
I understand the purpose of this research as mentioned above. I have been informed about diabetes and its acute 
and long-term effects on our body especially on eye, brain, heart, kidney, feet and nerve etc. During examination 
day I have to visit a selected area near my home in fasting state. Beside routine physical examination they will 
collect one tea spoon (5 ml) fasting blood from my vein. Then I have to drink a glass of glucose and after 2 hours 
they will again collect half spoon (3 ml) blood. My mental condition and dietary information’s will also be collected. 
They will provide all of my investigation reports and necessary advice.   
 
I understand that all the information which is obtained from me will be confidential in an appropriate manner.  
 
Participation is voluntary and I understand that I am free to refuse to participate in a procedure or to refuse to 
answer any question at any time without prejudice to me. I understand that I am free to withdraw my consent and 
to withdraw from the study any time without prejudice to me.  
 
I understand that the research investigators named above will answer any of my questions about the research 
procedures, my rights as a subjects and research-related injuries time. 
 
 
I understand that I will be given a copy of this consent form if I so request.  
 
 
Name and signature of participant or responsible Agent /Date 
 
……………………………………………………………………….. 
 
……………………………………………………………………….. 
 
Note: If you have any questions or complaints about the informed consent process or policy, please contact 
investigators (s). Thank you! 
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Appendix IV: Questionnaire of Chandra Rural Diabetes Study 
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Appendix V: Ethical Permission from Regional Ethical Committee, Norway 
 
 
 
 
 
 
 
 
Region: Officer: Phone:  Our date: Reference:
REC south-east Gjøril Bergva 22845529
 
03.07.2013 2013/1016/REK sør-øst
D
 Your date:
 28.05.2013
 
 
Besøksadresse:
Gullhaugveien 1-3, 0484 Oslo  
Telefon: 22845511
E-post: post@helseforskning.etikkom.no
Web: http://helseforskning.etikkom.no/
 
All post og e-post som inngår i
saksbehandlingen, bes adressert til REK
sør-øst og ikke til enkelte personer
 
Kindly address all mail and e-mails to
the Regional Ethics Committee, REK
sør-øst, not to individual staff
 
To Tasnima Siddiquee
2013/1016  Prevalence of overweight and obesity and its associated risk of diabetes in a rural Bangladeshi
population.
In reference to your application reviewed by the Committee on the 13th of June 2013.
 Tasnima SiddiqueeChief Investigator:
 University of  OsloInstitution responsible:
Project description
Developing countries are increasingly vulnerable to the worldwide epidemic of obesity and diabetes.
Obesity is a modifiable risk factor for type 2 diabetes (DM). Population-based data on the prevalence of
obesity in rural Bangladeshi adults based on proposed cut off points for Asian population have been lacking
until recently. The purpose of the study, which is a retrospective epidemiological study, is to determine the
prevalence of obesity and its associated risk of diabetes in rural Bangladeshi population. Data will be
ectracted from Chandra Rural Diabetes Study, a population-based cross-sectional study conducted in
March 2009 to December 2009. Prevalence of obesity and its diabetes risk will be assessed and their
relationships will be examined.
Committee’s considerations
The Committee reviewed the application during its meeting on 13 June 2013. The project was assessed in
accordance to the Norwegian Research Ethics Act of 30 June 2006 and Act on medical and health research
(the Health Research Act) of 20 June 2008 for the regional committees for medical and health research
ethics.
The Committee has no objections that the project is conducted as described in the application and the
protocol. The Committee presumes that Professor Akhtar Hussain is chief investigator, not the student.
It is stated in the application under point 5 that “Data registered in the research project are directly
identifiable”. The Committee requests that the data must be stored as de-identified data, i.e. with identifying
information kept separate from the other data.
The Committee’s decision
The project is approved on condition that it is conducted as described in the application and the protocol.
The approval is valid until 31.12.2013. The data must be stored as de-identified data, i.e. with identifying 
information kept separate from the other data. For purposes of documentation, the data shall be kept until
31.12.2018, and deleted or anonymized after this date.
The decision of the committee may be appealed to the National Committee for Research Ethics in Norway.
The appeal should be sent to the Regional Committee for Research Ethics in Norway, South-East D. The
deadline for appeals is three weeks from the date on which you receive this letter.
Yours Sincerely,
Stein A. Evensen
Prof. dr. med.
Chair of the Regional Committee for
Medical Research Ethics of Southern Norway (P.P.)
Section D
Gjøril Bergva
Advisor
Copy: ; hussain.akhtar@medisin.uio.no universitetsdirektor@uio.no  
